Introduction {#s1}
============

Land plants are characterized by the alternation of haploid (gametophyte) and diploid (sporophyte) phases within their lifecycle, both of which are multicellular ([@bib57]; [@bib11]). In the earliest diverging bryophyte lineages (liverworts, mosses and hornworts) the free-living indeterminate gametophyte predominates the lifecycle, producing gametes that fuse to form the sporophyte. The sporophyte embryo develops on the surface of the gametophyte, ultimately forming a simple determinate spore-producing axis ([@bib36]; [@bib42]). By contrast, angiosperm (flowering plant) sporophytes range from small herbaceous to large arborescent forms, all developing from an indeterminate vegetative shoot apex that ultimately transitions to flowering, and gametophytes are few-celled determinate structures produced within flowers ([@bib70]). A series of developmental innovations during the course of land plant evolution thus simplified gametophyte form whilst increasing sporophyte complexity, with a prolonged and plastic phase of vegetative development arising in the sporophyte of all vascular plants (lycophytes, ferns, gymnosperms and angiosperms).

Studies aimed at understanding how gene function evolved to facilitate developmental innovations during land plant evolution have thus far largely relied on comparative analyses between bryophytes and angiosperms, lineages that diverged over 450 million years ago. Such comparisons have revealed examples of both sub- and neo-functionalization following gene duplication, and of co-option of existing gene regulatory networks into new developmental contexts. For example, a single bHLH transcription factor in the moss *Physcomitrella patens* regulates stomatal differentiation, whereas gene duplications have resulted in three homologs with sub-divided stomatal patterning roles in the angiosperm *Arabidopsis thaliana* (hereafter 'Arabidopsis') ([@bib44]); class III HD-ZIP transcription factors play a conserved role in the regulation of leaf polarity in *P. patens* and Arabidopsis but gene family members have acquired regulatory activity in meristems of angiosperms ([@bib90]); and the gene regulatory network that produces rhizoids on the gametophytes of both the moss *P. patens* and the liverwort *Marchantia polymorpha* has been co-opted to regulate root hair formation in Arabidopsis sporophytes ([@bib48]; [@bib58]; [@bib62]). In many cases, however, interpreting the evolutionary trajectory of gene function by comparing lineages as disparate as bryophytes and angiosperms has proved challenging, particularly when only a single representative gene remains in most extant taxa -- as is the case for the *LEAFY* (*LFY*) gene family ([@bib30]; [@bib45]; [@bib69]).

The LFY transcription factor, which is present across all extant land plant lineages and related streptophyte algae ([@bib69]), has distinct functional roles in bryophytes and angiosperms. In *P. patens*, LFY regulates cell divisions during sporophyte development (including the first division of the zygote) ([@bib75]), whereas in angiosperms the major role is to promote the transition from inflorescence to floral meristem identity ([@bib17]; [@bib71]; [@bib84]; [@bib9]; [@bib73]; [@bib51]). Given that LFY proteins from liverworts and all vascular plant lineages tested to date (ferns, gymnosperms and angiosperms) bind a conserved target DNA motif, whereas hornwort and moss homologs bind to different lineage-specific motifs ([@bib69]), the divergent roles in mosses and angiosperms may have arisen through the activation of distinct networks of downstream targets. This suggestion is supported by the observation that PpLFY cannot complement loss-of-function *lfy* mutants in Arabidopsis ([@bib45]). Similar complementation studies indicate progressive functional changes as vascular plant lineages diverged in that the *lfy* mutant is not complemented by lycophyte LFY proteins ([@bib89]) but is partially and progressively complemented by fern and gymnosperm homologs ([@bib45]). Because LFY proteins from ferns, gymnosperms and angiosperms recognize the same DNA motif, this progression likely reflects co-option of an ancestral *LFY* gene regulatory network into different developmental contexts. As such, the role in floral meristem identity in angiosperms would have been co-opted from an unknown ancestral context in non-flowering vascular plants, a context that cannot be predicted from existing bryophyte data.

The role of *LFY* in non-flowering vascular plant lineages has thus far been hypothesized on the basis of expression patterns in the lycophyte *Isoetes sinensis* ([@bib89]), several gymnosperm species ([@bib47]; [@bib53]; [@bib72]; [@bib15]; [@bib81]; [@bib16]) and the fern *Ceratopteris richardii* (hereafter 'Ceratopteris') ([@bib30]), which has been used as a model of fern development for a number of years ([@bib28]). These studies reported broad expression in vegetative and reproductive sporophyte tissues of *I. sinensis* and gymnosperms, and in both gametophytes and sporophytes of Ceratopteris. Although gene expression can be indicative of potential roles in each case, the possible evolutionary trajectories and differing ancestral functions proposed for *LFY* within the vascular plants ([@bib77]; [@bib54]) cannot be resolved without functional validation. Here we present a functional analysis in Ceratopteris that reveals a stem cell maintenance role for at least one of the two *LFY* homologs in both gametophyte and sporophyte shoots and discuss how that role informs our mechanistic understanding of developmental innovations during land plant evolution.

Results {#s2}
=======

The *CrLFY1* and *CrLFY2* genes duplicated recently within the fern lineage {#s2-1}
---------------------------------------------------------------------------

The *LFY* gene family is present as a single gene copy in most land plant genomes ([@bib69]). In this regard, the presence of two *LFY* genes in Ceratopteris ([@bib30]) is atypical. To determine whether this gene duplication is more broadly represented within the ferns and related species (hereafter 'ferns'), a previous amino acid alignment of LFY orthologs ([@bib69]) was pruned and supplemented with newly-available fern homologs (see Materials and methods) to create a dataset of 120 sequences,\~50% of which were from the fern lineage ([Supplementary file 1](#supp1){ref-type="supplementary-material"}--[3](#supp3){ref-type="supplementary-material"}). The phylogenetic topology inferred within the vascular plants using the entire dataset ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) was consistent with previous analyses ([@bib63]; [@bib87]). Within the ferns (64 in total), phylogenetic relationships between *LFY* sequences indicated that the two gene copies identified in *Equisetum arvense*, *Azolla caroliniana* and Ceratopteris each resulted from recent independent duplication events ([Figure 1](#fig1){ref-type="fig"}). Gel blot analysis confirmed the presence of no more than two *LFY* genes in the Ceratopteris genome ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Given that the topology of the tree excludes the possibility of a gene duplication prior to diversification of the ferns, *CrLFY1* and *CrLFY2* are equally orthologous to the single copy *LFY* representatives in other fern species.

![*CrLFY1* and *CrLFY2* arose from a recent gene duplication event.\
Inferred phylogenetic tree from maximum likelihood analysis of 64 LFY amino acid sequences (see [Supplementary file 1](#supp1){ref-type="supplementary-material"} for accession numbers) sampled from within the fern lineage plus lycophyte sequences as an outgroup. Bootstrap values are given for each node. The tree shown is extracted from a phylogeny with representative sequences from all land plant lineages ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). The *Ceratopteris richardii* genome contains no more than two copies of LFY ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}; indicated by **\***). Different taxonomic clades within the fern lineage are denoted by different colours, as shown. The divergence between eusporangiate and leptosporangiate ferns is indicated by arrows.](elife-39625-fig1){#fig1}

*CrLFY1* and *CrLFY2* transcripts accumulate differentially during the Ceratopteris lifecycle {#s2-2}
---------------------------------------------------------------------------------------------

The presence of two *LFY* genes in the Ceratopteris genome raises the possibility that gene activity was neo- or sub-functionalized following duplication. To test this hypothesis, transcript accumulation patterns of *CrLFY1* and *CrLFY2* were investigated throughout the Ceratopteris lifecycle (shown as a schematic in [Figure 2](#fig2){ref-type="fig"} for reference).

![The lifecycle of *Ceratopteris richardii*.\
Ceratopteris propagates in the haploid gametophyte phase of its lifecycle (**n**) through single-celled spores (**A**) On spore germination (**B**) a two-dimensional photosynthetic thallus develops into one of two sexes, a default hermaphrodite (**C**) which produces eggs and sperm (**D**) or a hormone-induced male that produces sperm only (**E**). Eggs are retained on the hermaphrodite thallus, and fertilization results in the development of a diploid (2n) embryo on the gametophyte (**F**), initiating the sporophyte phase of the lifecycle. The sporophyte establishes a vegetative shoot that initiates leaflike lateral organs (fronds) and roots from its apex (**G**). The first fronds produced are simple but later fronds become increasingly lobed and dissected (**H, I**). The sporophyte undergoes a reproductive phase-change and subsequent fronds generate haploid spores by meiosis on their undersides (**J**), enclosed in a morphologically-distinct curled lamina. Mature spores are dispersed to restart the lifecycle.](elife-39625-fig2){#fig2}

The developmental stages sampled spanned from imbibed spores prior to germination of the haploid gametophyte ([Figure 3A](#fig3){ref-type="fig"}), to differentiated male and hermaphrodite gametophytes ([Figure 3B--D](#fig3){ref-type="fig"}), through fertilization and formation of the diploid sporophyte embryo ([Figure 3E](#fig3){ref-type="fig"}), to development of the increasingly complex sporophyte body plan ([Figure 3F--K](#fig3){ref-type="fig"}). Quantitative real-time PCR (qRT-PCR) analysis detected transcripts of both *CrLFY1* and *CrLFY2* at all stages after spore germination, but only *CrLFY2* transcripts were detected in spores prior to germination ([Figure 3L](#fig3){ref-type="fig"}). A two-way ANOVA yielded a highly significant interaction (F(10,22) = 14.21; p\<0.0001) between gene copy and developmental stage that had not been reported in earlier studies ([@bib30]), and is indicative of differential gene expression between *CrLFY1* and *CrLFY2* that is dependent on developmental stage. Of particular note were significant differences between *CrLFY1* and *CrLFY2* transcript levels during sporophyte development ([Supplementary file 4](#supp4){ref-type="supplementary-material"}). Whereas *CrLFY2* transcript levels were similar across sporophyte samples, *CrLFY1* transcript levels were much higher in samples that contained the shoot apex ([Figure 3F,G](#fig3){ref-type="fig"}) than in those that contained just fronds ([Figure 3H--K](#fig3){ref-type="fig"}). These data suggest that *CrLFY1* and *CrLFY2* genes may play divergent roles during sporophyte development, with *CrLFY1* acting primarily in the shoot apex and *CrLFY2* acting more generally.

![*CrLFY1* and *CrLFY2* are differentially expressed during the Ceratopteris lifecycle.\
(**A-K**) Representative images of the developmental stages sampled for expression analysis in (**L**). Imbibed spores (**A**); populations of developing gametophytes harvested at 5 (**B, C**) and 8 (**D**) days after spore-sowing (DPS), comprising only males (**B**) or a mixture of hermaphrodites (**h**) and males (**m**) (**C, D**); fertilized gametophyte subtending a developing sporophyte embryo (em) (**E**); whole sporophyte shoots comprising the shoot apex with 3 (**F**) or five expanded entire fronds attached (**G**); individual vegetative fronds demonstrating a heteroblastic progression in which frond complexity increases through successive iterations of lateral outgrowths (pinnae) (**H--J**); complex fertile frond with sporangia on the underside of individual pinnae (**K**). Scale bars = 100 um (**A--E**), 5 mm (**F--H**), 20 mm (**I--K**). (**L**) Relative expression levels of *CrLFY1* and *CrLFY2* (normalized against the housekeeping genes *CrACTIN1* and *CrTBP*) at different stages of development. *n* = 3; Error bars = standard error of the mean (SEM). Pairwise statistical comparisons (ANOVA followed by Tukey's multiple comparisons test-- [Supplementary file 4](#supp4){ref-type="supplementary-material"}) found no significant difference in *CrLFY2* transcript levels between any gametophyte or sporophyte tissues sampled after spore germination (p\>0.05) and no significant difference between *CrLFY1* and *CrLFY2* transcript levels during early gametophyte development (p\>0.05) (**B, C**). Differences between *CrLFY1* and *CrLFY2* transcript levels were significant in gametophytes at 8 DPS (p\<0.05) (**D**). *CrLFY1* transcript levels were significantly higher in whole young sporophytes (**F**) and vegetative shoots (**G**) compared to isolated fronds (**H--K**) (p\<0.05). *CrLFY1* transcript levels in whole sporophytes and shoots were greater than *CrLFY2*, whereas in isolated fronds *CrLFY1* transcript levels were consistently lower than *CrLFY2* (p\<0.05). Asterisks denote significant difference (\*, p\<0.05; \*\*, p\<0.01, \*\*\*, p\<0.001; \*\*\*\*, p\<0.0001) between *CrLFY1* and *CrLFY2* transcript levels (Sidak's multiple comparisons test) within a developmental stage. Letters denote significant difference (p\<0.05) between developmental stages for *CrLFY1* or *CrLFY2* (Tukey's test). Groups marked with the same letter are not significantly different from each other (p\>0.05). Statistical comparisons between developmental stages were considered separately for *CrLFY1* and *CrLFY2*. The use of different letters between *CrLFY1* and *CrLFY2* does not indicate a significant difference.\
10.7554/eLife.39625.008Figure 3---source data 1.CrLFY qRT-PCR ontogenic expression data](elife-39625-fig3){#fig3}

Spatial expression patterns of *CrLFY1* are consistent with a retained ancestral role to facilitate cell divisions during embryogenesis {#s2-3}
---------------------------------------------------------------------------------------------------------------------------------------

Functional characterization in *P. patens* previously demonstrated that PpLFY promotes cell divisions during early sporophyte development ([@bib75]). To determine whether the spatial domains of *CrLFY1* expression are consistent with a similar role in Ceratopteris embryo (early sporophyte) development, transgenic lines were generated that expressed the reporter gene B-glucuronidase (GUS) driven by a 3.9 kb fragment of the *CrLFY1* promoter (*CrLFY1~pro~::GUS*). This promoter fragment comprised genomic sequence encoding the entire published 5'UTR ([@bib30]) plus a further 1910 bp upstream of the predicted transcription start site ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). In the absence of a genome sequence, repeated attempts to isolate an analogous fragment of *CrLFY2* sequence were unsuccessful (see Materials and methods for details). Construct maps plus DNA blot and PCR validation of transgenic lines are shown in [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"}--[4](#fig4s4){ref-type="fig"}. GUS activity was monitored in individuals from three independent transgenic lines, sampling both before and up to six days after fertilization ([Figure 4A--O](#fig4){ref-type="fig"}), using wild-type individuals as negative controls ([Figure 4P--T](#fig4){ref-type="fig"}) and individuals from a transgenic line expressing GUS driven by the constitutive 35S promoter (*35S~pro~*) as positive controls ([Figure 4U--Y](#fig4){ref-type="fig"}). Notably, no GUS activity was detected in unfertilized archegonia of *CrLFY1~pro~::GUS* gametophytes ([Figure 4A,F,K](#fig4){ref-type="fig"}) but by two days after fertilization (DAF) GUS activity was detected in most cells of the early sporophyte embryo ([Figure 4B,G,L](#fig4){ref-type="fig"}). At 4 DAF, activity was similarly detected in all visible embryo cells, including the embryonic frond, but not in the surrounding gametophytic tissue (the calyptra) ([Figure 4C,H,M](#fig4){ref-type="fig"}). This embryo-wide pattern of GUS activity became restricted in the final stages of development such that by the end of embryogenesis (6 DAF) GUS activity was predominantly localized in the newly-initiated shoot apex ([Figure 4D,E,I,J,N,O](#fig4){ref-type="fig"}). Collectively, the GUS activity profiles indicate that *CrLFY1* expression is induced following formation of the zygote, sustained in cells of the embryo that are actively dividing, and then restricted to the shoot apex at embryo maturity. This profile is consistent with the suggestion that *CrLFY1* has retained the LFY role first identified in *P. patens* ([@bib75]), namely to promote the development of a multicellular sporophyte, in part by facilitating the first cell division of the zygote.

![The *CrLFY1* promoter drives reporter gene expression in proliferating tissues of the developing Ceratopteris embryo.\
(**A--Y**) GUS activity detected as blue staining in developing embryos of three independent *CrLFY1~pro~::GUS* transgenic reporter lines (**A--O**), a representative negative wild-type control line (**P--T**) and a representative positive *35S~pro~::GUS* control line (**U--Y**). Tissues are shown prior to fertilization (**A, F, K, P, U**), or 2 (**B, G, L, Q, V**), 4 (**C, H, M, R, W**), and 6 (**D, I, N, S, X**) days after fertilization (DAF). In *CrLFY1~pro~::GUS* lines, GUS activity first became visible within the first few divisions of embryo development (but not in surrounding gametophyte tissues) at 2 DAF (**B, G, L**) and was expressed in cells of the embryo frond as it proliferated (**C, H, M**). GUS activity was visible in the shoot apex and in frond vascular tissue at 6 DAF (**D, I, N**), with staining in the shoot apical cell (sac), subtending shoot apex tissues and newly-initiated fronds, including the frond apical cell (fac) (**E, J, O**). No GUS activity was detected in wild-type samples (**P--T**), whereas the majority of cells in the constitutively expressing *35S~pro~::GUS* samples stained blue (**U--Y**). Embryos develop on the surface of the gametophyte thallus when an egg cell (ec) within the archegonium (which comprises a venter (**v**) and neck cells (nc) to allow sperm entry) are fertilized. After fertilization, the venter forms a jacket of haploid cells known as the calyptra (**c**) that surrounds the diploid embryo (em). Cell fates in the embryo (embryo frond (fr), embryo foot (ft), root apex (ra) and shoot apex (sa)) are established at the eight-celled stage ([@bib34]), which is around 2 DAF under our growth conditions. Embryogenesis is complete at 6 DAF, after which fronds arise from the shoot apex. Scale bars = 50 μm.](elife-39625-fig4){#fig4}

*CrLFY1* is expressed in dividing tissues throughout shoot development {#s2-4}
----------------------------------------------------------------------

Both mosses and ferns form embryos, but moss sporophyte development is determinate post-embryogenesis ([@bib36]; [@bib38]) whereas fern sporophytes are elaborated post-embryonically from indeterminate shoot apices ([@bib7]; [@bib86]). The Ceratopteris shoot apex comprises a single apical cell that generates daughter cells through asymmetric divisions, and individual lateral organs (fronds and root) arise from their own apical cells specified within the grouped descendants of these daughter cells ([@bib32]; [@bib33]). *CrLFY1~pro~::GUS* expression in the shoot apex at the end of embryogenesis ([Figure 4E,J,O](#fig4){ref-type="fig"}) and elevated transcript levels in shoot apex-containing sporophyte tissues ([Figure 3L](#fig3){ref-type="fig"}) suggested an additional role for *CrLFY1* relative to that seen in mosses, namely to promote proliferation in the indeterminate shoot apex. To monitor *CrLFY1* expression patterns in post-embryonic sporophytes, GUS activity was assessed in *CrLFY1~pro~::GUS* lines at two stages of vegetative development ([Figure 5A--O](#fig5){ref-type="fig"}) and after the transition to reproductive frond formation ([Figure 5---figure supplement 1A--L](#fig5s1){ref-type="fig"}). Wild-type individuals were used as negative controls ([Figure 5P--T](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1M--P](#fig5s1){ref-type="fig"}) and *35S~pro~::GUS* individuals as positive controls ([Figure 5U--Y](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1Q--T](#fig5s1){ref-type="fig"}). In young sporophytes (20 DAF), GUS activity was primarily localized in shoot apical tissues and newly-emerging frond primordia ([Figure 5A,F,K](#fig5){ref-type="fig"}), with very little activity detected in the expanded simple fronds produced at this age ([Figure 5B,G,L](#fig5){ref-type="fig"}). In older vegetative sporophytes (60 DAF), which develop complex dissected fronds ([Figure 5C,H,M](#fig5){ref-type="fig"}), GUS activity was similarly localized in the shoot apex and young frond primordia in two out of the three fully characterized lines ([Figure 5D,I,N](#fig5){ref-type="fig"}) and in a total of 8 out of 11 lines screened (from seven independent rounds of plant transformation). GUS activity was also detected in developing fronds in regions where the lamina was dividing to generate pinnae and pinnules ([Figure 5E,J,O](#fig5){ref-type="fig"}). In some individuals GUS activity could be detected in frond tissues almost until maturity ([Figure 5C](#fig5){ref-type="fig"}). Notably, patterns of *CrLFY1~pro~::GUS* expression were the same in the apex and complex fronds of shoots before (60 DAF) ([Figure 5C--E,H--J,M--O](#fig5){ref-type="fig"}) and after (\~115 DAF) the reproductive transition ([Figure 5---figure supplement 1A--L](#fig5s1){ref-type="fig"}). Consistent with a general role for *CrLFY1* in promoting cell proliferation in the shoot, GUS activity was also detected in shoot apices that initiate *de novo* at the lamina margin between pinnae ([Figure 5Z--AD](#fig5){ref-type="fig"}). Together these data support the hypothesis that *LFY* function was recruited to regulate cell division processes in the shoot when sporophytes evolved from determinate to indeterminate structures.

![The *CrLFY1* promoter drives reporter gene expression in proliferating shoot tissues of the Ceratopteris sporophyte.\
(**A--Y**) GUS activity detected as blue staining in post-embryonic sporophytes from three independent *CrLFY1~pro~::GUS* transgenic reporter lines (**A--O**), negative wild-type controls (**P--T**) and positive *35S~pro~::GUS* controls (**U--Y**). Sporophytes were examined at 20 DAF (**A, B, F, G, K, L, P, Q, U, V**) and 60 DAF (**C--E, H--J, M--O, R--T, W--Y**). GUS staining patterns are shown for whole sporophytes (**A, C, F, H, K, M, P, R, U, W**), shoot apices (arrowheads) (**B, D, G, I, L, N, Q, S, V, X**) and developing fronds (**E, J, O, T, Y**). In *CrLFY1~pro~::GUS* sporophytes at 20 DAF (producing simple, spade-like fronds) GUS activity was restricted to the shoot apex (**A, F, K**) and newly-initiated frond primordia, with very low activity in expanded fronds (**B, G, L**). In *CrLFY1~pro~::GUS* sporophytes at 60 DAF (producing complex, highly dissected fronds) GUS activity was similarly seen in the apex (**C, H, M**), but persisted for longer during frond development. Activity was initially detected throughout the frond primordium (**D, I, N**), before becoming restricted to actively proliferating areas of the lamina (**E, J, O**). Scale bars = 2 mm (**A, F, K, P, U**), 500 μm (**B, D, G, I, L, N, Q, S, V, X**) 10 mm (**C, H, M, R, W**), 1 mm (**E, J, O, T, Y**). \*=GUS staining in maturing frond. GUS staining patterns were the same in leaves formed after the reproductive transition ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). (**Z-AD**) Fronds can initiate *de novo* shoots (white arrowheads) from marginal tissue between existing frond pinnae (**Z, AA**). GUS activity was detected in emerging de novo shoot apices on *CrLFY1~pro~::GUS* fronds (**AB--AD**). Scale bars = 10 mm (**Z, AA**), 500 μm (**AB--AD**).](elife-39625-fig5){#fig5}

*CrLFY1* regulates activity of the sporophyte shoot apex {#s2-5}
--------------------------------------------------------

To test the functional significance of *CrLFY* expression patterns, transgenic RNAi lines were generated in which one of four RNAi constructs targeted to *CrLFY1, CrLFY2* or both were expressed from the maize ubiquitin promoter (*ZmUbi~pro~*). Construct maps plus DNA blot and PCR validation of transgenic lines are shown in [Figure 6---figure supplements 1](#fig6s1){ref-type="fig"}--[5](#fig6s5){ref-type="fig"}. Genotypic screening identified 10 lines which contained the complete transgene cassette and three lines that contained a fragment of the transgene which included the antibiotic resistance marker but not the RNAi hairpin ([Table 1](#table1){ref-type="table"}).

10.7554/eLife.39625.016

###### Summary of *CrLFY* RNAi transgenic lines and their phenotypic characterization.

Transgenic lines exhibited gametophytic developmental arrest and/or sporophyte shoot termination at varying stages of development. '+' indicates that a particular line was phenotypically normal at the developmental stage indicated, '−' indicates that development had arrested at or prior to this stage. In lines marked '+/-' the stage at which developmental defects occurred varied between individuals within the line, and at least some arrested individuals were identified at the stage indicated. The five *ZmUbi~pro~::CrLFY1/2-i1* lines shown were generated from three rounds of transformation, the pairs of lines B16 and B19 and D2 and D4 potentially arising from the same transformation event. The no hairpin control lines NHC-2 (F3) and NHC-3 (F4) may similarly have arisen from a single transformation event. In all other cases, each transgenic line arose from a separate round of transformation and so must represent independent T-DNA insertions.

  RNAi transgene              Line   Transfor-mation replicate   Gametophyte phase   Sporophyte phase                                      
  --------------------------- ------ --------------------------- ------------------- ------------------ ----- -------- ---- ---- ---- ---- ------
  *ZmUBI~pro~::CrLFY1/2-i1*   B16    1                           \+                  \-                 \-    99.86    \+   \+   \-   \-   \<5%
  *ZmUBI~pro~::CrLFY1/2-i1*   B19    1                           \+                  \-                 \-    50.00    \+   \+   \+   \-   \<5%
  *ZmUBI~pro~::CrLFY1/2-i1*   D13    2                           \+                  \-                 \-    99.80    \+   \+   \-   \-   \<5%
  *ZmUBI~pro~::CrLFY1/2-i1*   D2     3                           \+                  \+                 \+    0.00     \+   \+   \-   \-   \<5%
  *ZmUBI~pro~::CrLFY1/2-i1*   D4     3                           \+                  \+                 \+    0.00     \+   \+   \+   \+   \<5%
  *ZmUBI~pro~::CrLFY1/2-i2*   F9     4                           \+                  \-                 \-    0.00     \+   \+   \-   \-   \<5%
  *ZmUBI~pro~::CrLFY1/2-i2*   F14    5                           \-                  \-                 \-    100.00   \-   \-   \-   \-   0
  *ZmUBI~pro~::CrLFY1-i3*     E8     6                           \+                  +/-                +/-   100.00   \-   \-   \-   \-   0
  *ZmUBI~pro~::CrLFY1-i3*     G13    7                           \+                  \+                 \+    0.00     \+   \+   \-   \-   \<5%
  *ZmUBI~pro~::CrLFY2-i4*     C3     8                           \+                  \+                 \+    0.00     \+   \+   \-   \-   \<5%
  NHC-1 (control)             D20    9                           \+                  \+                 \+    0.00     \+   \+   \+   \+   0
  NHC-2 (control)             F3     10                          \+                  \+                 \+    0.00     \+   \+   \+   \+   0
  NHC-3 (control)             F4     10                          \+                  \+                 \+    0.00     \+   \+   \+   \+   0

In the no hairpin control (NHC) plants, post-embryonic shoot development initiated with the production of simple, spade-like fronds from the shoot apex ([Figure 6A](#fig6){ref-type="fig"}) as in wild type. In eight transgenic lines, sub-populations of sporophytes developed in which this early stage of sporophyte development was perturbed, one line (E8) failing to initiate recognizable embryos ([Figure 6B](#fig6){ref-type="fig"}) and the remainder exhibiting premature shoot apex termination, typically after producing several distorted fronds ([Figure 6C--H](#fig6){ref-type="fig"}). Sub-populations of phenotypically normal transgenic sporophytes were also identified in some of these lines ([Figure 6I--L](#fig6){ref-type="fig"}). The two remaining lines exhibited less severe shoot phenotypes, one undergoing shoot termination after the production of simple (B19a) or lobed (B19b) fronds at the stage when control sporophytes produced complex dissected fronds ([Figure 6M--O](#fig6){ref-type="fig"}), and the other (D4b) completing sporophyte development but reduced in size to approximately 50% of controls ([Figure 6P,Q](#fig6){ref-type="fig"}). Despite the predicted sequence specificity of *CrLFY1-i3* and *CrLFY2-i4* ([Supplementary file 5](#supp5){ref-type="supplementary-material"}), qRT-PCR analysis found that all four RNAi constructs led to suppressed transcript levels of both *CrLFY* genes ([Figure 6R,S](#fig6){ref-type="fig"}). The severity of the shoot phenotype was correlated with the level of endogenous *CrLFY* transcripts detected across all lines ([Figure 6R,S](#fig6){ref-type="fig"}), with relative levels of both *CrLFY1* and *CrLFY2* significantly reduced compared to controls in all early-terminating sporophytes (E8, G13, C3, D2, D4a, D13, F9) (p\<0.01 or less). In phenotypically normal transgenic siblings *CrLFY2* transcript levels were not significantly lower than controls (indeed in line D2, levels were higher p\<0.01) whereas *CrLFY1* levels were significantly reduced (p\<0.0001), as in arrested siblings. Together, these data indicate that *CrLFY2* can compensate for some loss of *CrLFY1*, but at least 22% of *CrLFY1* activity is required for normal development (line D4a pn, [Figure 6J,S](#fig6){ref-type="fig"}). It can thus be concluded that *CrLFY1* and *CrLFY2* act partially redundantly to maintain indeterminacy of the shoot apex in Ceratopteris, a role not found in the early divergent bryophyte *P. patens*, nor known to be retained in the majority of later diverging flowering plants.

![Suppression of *CrLFY* expression causes early termination of the Ceratopteris sporophyte shoot apex.\
(**A-L**) Sporophyte phenotype 25 days after fertilization (DAF) in no hairpin control, NHC-1 (**A**) and transgenic lines carrying RNAi constructs against *CrLFY1* (*ZmUbi~pro~::CrLFY1-i3*) (**B, C**), *CrLFY2* (*ZmUbi~pro~::CrLFY1-i4*) (**D**) and both *CrLFY1* and *CrLFY2* (*ZmUbi~pro~::CrLFY1/2-i1* and *ZmUbi~pro~::CrLFY1/2-i2*) (**E--L**). In some lines, both aborted and phenotypically normal sporophytes were identified (compare **E** and **I**; **F** and **J**; **G** and **K**; **H** and **L**). The presence of the RNAi transgene in phenotypically normal sporophytes was validated by genotyping ([Figure 6---figure supplement 5](#fig6s5){ref-type="fig"}). Scale bars = 1 mm (**A--H**), 5 mm (**I--L**). (**M--Q**) Sporophyte phenotype of two no hairpin control (NHC-3 and NHC-1) (**M, P**) and two *ZmUbi~pro~::CrLFY1/2-i1* (**N, O**) lines at 63 (**M--O**) and 76 (**P,Q**) DAF. (**R, S**) qRT-PCR analysis of *CrLFY1* and *CrLFY2* transcript levels (normalized against the averaged expression of reference genes *CrACTIN1* and *CrTBP*) in the sporophytes of the RNAi lines shown in (**A--L**). Transcript levels are depicted relative to no hairpin controls (NHC-1or −3), *n* = 3, error bars = standard error of the mean (SEM). *CrLFY1* and *CrLFY2* expression levels were significantly reduced compared to controls (p\<0.01 or less) in all transgenic lines where sporophyte shoots undergo early termination (**A--H**), but in phenotypically normal (pn) sporophytes segregating in the same lines (**I--L**), only *CrLFY1* transcript levels were reduced (p\<0.0001). *CrLFY2* transcript levels in pn sporophytes were not significantly lower than in controls. Asterisks denote level of significant difference from controls (\*\*p\<0.01, \*\*\*p\<0.001; \*\*\*\*p\<0.0001).\
10.7554/eLife.39625.023Figure 6---source data 1.CrLFY RNAi lines qRT-PCR expression data](elife-39625-fig6){#fig6}

*CrLFY* promotes apical cell divisions in the gametophyte {#s2-6}
---------------------------------------------------------

In six of the RNAi lines that exhibited sporophyte developmental defects, it was notable that 50--99% of gametophytes arrested development prior to the sporophyte phase of the lifecycle ([Table 1](#table1){ref-type="table"}). This observation suggested that LFY plays a role in Ceratopteris gametophyte development, a function not previously demonstrated in either bryophytes or angiosperms. During wild-type development, the Ceratopteris gametophyte germinates from a single-celled haploid spore, establishing a single apical cell (AC) within the first few cell divisions ([Figure 7A](#fig7){ref-type="fig"}). Divisions of the AC go on to form a two-dimensional photosynthetic thallus in both the hermaphrodite, where a notch meristem takes on growth ([Figure 7B](#fig7){ref-type="fig"}), and male sexes ([Figure 7C](#fig7){ref-type="fig"}) ([@bib4]). In contrast, the gametophytes from six RNAi lines (carrying either *ZmUbi~pro~::CrLFY1-i3*, *ZmUbi~pro~::CrLFY1/2-i1* or *ZmUbi~pro~::CrLFY1/2-i2*) exhibited developmental arrest ([Figure 7D--J](#fig7){ref-type="fig"}), which in five lines clearly related to a failure of AC activity. The point at which AC arrest occurred varied, in the most severe line occurring prior to or during AC specification ([Figure 7D](#fig7){ref-type="fig"}) and in others during AC-driven thallus proliferation ([Figure 7E--I](#fig7){ref-type="fig"}). Failure of AC activity was observed in both hermaphrodites ([Figure 7E](#fig7){ref-type="fig"}) and males ([Figure 7H,I](#fig7){ref-type="fig"}). The phenotypically least-severe line exhibited hermaphrodite developmental arrest only after AC activity had been replaced by the notch meristem ([Figure 7J](#fig7){ref-type="fig"}). A role for *CrLFY* in maintenance of gametophyte AC activity was supported by the detection of *CrLFY* transcripts in the AC and immediate daughter cells of wild-type gametophytes by in situ hybridization ([Figure 7K--N](#fig7){ref-type="fig"}). By contrast *CrLFY* transcripts were not detected in arrested *ZmUbi~pro~::CrLFY1/2-i1* lines ([Figure 7O--R](#fig7){ref-type="fig"}) in which the presence of the transgene was confirmed by genotyping of individual arrested gametophytes ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). *CrLFY1* and *CrLFY2* transcripts could not be clearly distinguished in situ due to sequence similarity (see [Supplementary file 6](#supp6){ref-type="supplementary-material"}), and hence the observed phenotypes could not be ascribed to a specific gene copy. However, these data support a role for at least one *CrLFY* homolog in AC maintenance during gametophyte development, and thus invoke a role for LFY in the regulation of apical activity in both the sporophyte and gametophyte phases of vascular plant development.

![Suppression of *CrLFY* expression causes early termination of the Ceratopteris gametophyte apical cell.\
(**A--C**) In no hairpin control lines, the gametophyte established a triangular apical cell (ac) shortly after spore (sp) germination (**A**). Divisions of the apical cell established a photosynthetic thallus in both hermaphrodite and male gametophytes. At 10 days post spore sowing (DPS) both gametophyte sexes were approaching maturity, with the hermaphrodite (**B**) having formed a chordate shape from divisions at a lateral notch meristem (**n**) and having produced egg-containing archegonia (ar), sperm-containing antheridia (an), and rhizoids (rh). The male (**C**) had a more uniform shape with antheridia across the surface. These phenotypes were identical to wild-type. (**D--J**) When screened at 10--17 DPS, gametophytes from multiple RNAi lines (as indicated) exhibited developmental arrest, mostly associated with a failure of apical cell activity. Arrest occurred at various stages of development from failure to specify an apical cell, resulting in only a rhizoid being produced and no thallus (**D**) through subsequent thallus proliferation (**E--I**). Gametophyte development in one line progressed to initiation of the notch meristem but overall thallus size was severely reduced compared to wild-type (**J**). (**K--R**) In situ hybridization with antisense probes detected *CrLFY* transcripts in the apical cell and immediate daughter cells of wild-type gametophytes at 4 DPS (**K, M**). No corresponding signal was detected in controls hybridized with sense probes (**L, N**). In the arrested gametophytes of two *ZmUbi~pro~::CrLFY1/2-i1* lines *CrLFY* transcripts could not be detected (**O--R**), and transgene presence was confirmed ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Scale bars = 100 μm.](elife-39625-fig7){#fig7}

Discussion {#s3}
==========

The results reported here reveal a role for LFY in the maintenance of apical cell activity throughout gametophyte and sporophyte shoot development in Ceratopteris. During sporophyte development, qRT-PCR and transgenic reporter lines demonstrated that *CrLFY1* is preferentially expressed in the shoot apex (whether formed during embryogenesis or de novo on fronds, and both before and after the reproductive transition); in emerging lateral organ (frond) primordia; and in pinnae and pinnules as they form on dissected fronds ([Figures 3](#fig3){ref-type="fig"}--[5](#fig5){ref-type="fig"}). Notably, active cell division is the main feature in all of these contexts. *CrLFY2* transcript levels were more uniform throughout sporophyte shoot development, in both dividing tissues and expanded fronds ([Figure 3](#fig3){ref-type="fig"}), and expression has previously been reported in roots ([@bib30]). Simultaneous suppression of *CrLFY1* and *CrLFY2* activity by RNAi resulted in developmental arrest of both gametophyte and sporophyte shoot apices, with any fronds produced before termination of the sporophyte apex exhibiting abnormal morphologies ([Figures 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}). The severity of phenotypic perturbations in sporophytes of transgenic lines correlated with combined *CrLFY1* and *CrLFY2* transcript levels, with wild-type levels of *CrLFY2* able to fully compensate for up to a 70% reduction in *CrLFY1* levels ([Figure 6](#fig6){ref-type="fig"}). The duplicate *CrLFY* genes therefore act at least partially redundantly during shoot development in Ceratopteris.

A function for LFY in gametophyte development has not previously been reported in any land plant species. In the moss *P. patens, PpLFY1* and *PpLFY2* are expressed in both the main and lateral apices of gametophytic leafy shoots but double loss-offunction mutants develop normally, indicating that LFY is not necessary for maintenance of apical cell activity in the gametophyte ([@bib75]). By contrast, loss of *CrLFY* expression from the gametophyte shoot apex results in loss of apical cell activity during thallus formation in Ceratopteris ([Figure 7](#fig7){ref-type="fig"}). The different DNA binding site preferences (and hence downstream target sequences) of PpLFY and CrLFY ([@bib69]) may be sufficient to explain the functional distinction in moss and fern gametophytes, but the conserved expression pattern is intriguing given that there should be no pressure to retain that pattern in *P. patens* in the absence of functional necessity. The thalloid gametophytes of the two other extant bryophyte lineages (liverworts and hornworts) resemble the fern gametophyte more closely than mosses ([@bib42]), but LFY function in these contexts is not yet known. Overall the data are consistent with the hypothesis that in the last common ancestor of ferns and angiosperms, LFY functioned to promote cell proliferation in the thalloid gametophyte, a role that has been lost in angiosperms where gametophytes have no apical cell and are instead just few-celled determinate structures.

The range of reported roles for LFY in sporophyte development can be rationalized by hypothesizing three sequential changes in gene function during land plant evolution ([Figure 8](#fig8){ref-type="fig"}). First, the ancestral LFY function to promote early cell divisions in the embryo was retained in vascular plants after they diverged from the bryophytes, leading to conserved roles in *P. patens* ([@bib75]) and Ceratopteris ([Figure 4](#fig4){ref-type="fig"}). Second, within the vascular plants (preceding divergence of the ferns) this proliferative role expanded to maintain post-embryonic apical cell activity, and hence to enable indeterminate shoot growth. This is evidenced by *CrLFY* activity at the tips of shoots, fronds and pinnae ([Figures 4](#fig4){ref-type="fig"}--[6](#fig6){ref-type="fig"}), all of which develop from one or more apical cells ([@bib29]; [@bib33]). Whether fern fronds are homologous to shoots or to leaves in angiosperms is an area of debate ([@bib78]; [@bib80]; [@bib25]), but there are angiosperm examples of LFY function in the vegetative SAM ([@bib1]; [@bib92]), axillary meristems ([@bib35]; [@bib64]; [@bib18]) and in actively dividing regions of compound leaves ([@bib31]; [@bib51]; [@bib19]; [@bib82]; [@bib52]) indicating that a proliferative role in vegetative tissues has been retained in at least some angiosperm species. Consistent with the suggestion that the angiosperm floral meristem represents a modified vegetative meristem ([@bib76]), the third stage of LFY evolution could have been co-option and adaptation of this proliferation-promoting network into floral meristems, with subsequent restriction to just the flowering role in many species. This is consistent with multiple observations of *LFY* expression in both vegetative and reproductive shoots (developing cones) in gymnosperms ([@bib47]; [@bib53]; [@bib72]; [@bib15]; [@bib81]; [@bib16]; [@bib55]) and suggests that pre-existing *LFY*-dependent vegetative gene networks might have been co-opted during the origin of specialized sporophyte reproductive axes in ancestral seed plants, prior to the divergence of angiosperms.

![Evolutionary trajectory of LFY function.\
The phylogeny was reconstructed from selected LFY protein sequences representing all extant embryophyte lineages (as highlighted) and the algal sister-group. Coloured bars at the terminal branches represent different developmental functions of LFY determined from functional analysis in those species (see [Supplementary file 8](#supp8){ref-type="supplementary-material"} for references). Coloured numbers indicate the putative points of origin of different functions inferred from available data points across the tree. 1, cell division within the sporophyte zygote; 2, maintenance of indeterminate cell fate in vegetative shoots through proliferation of one or more apical cells (AC); 2a, maintenance of indeterminate cell fate in vegetative lateral/axillary apices; 2b, maintenance of indeterminate cell fate in the margins of developing lateral organs (compound leaves); 3, specification of floral meristem identity (determinate shoot development producing modified lateral organs) and shoot transition to the reproductive phase; 3a, maintenance of indeterminate cell fate in inflorescence lateral/branch meristems (in place of floral meristem fate).](elife-39625-fig8){#fig8}

The proposed evolutionary trajectory for LFY function bears some resemblance to that seen for KNOX protein function. Class I *KNOX* genes are key regulators of indeterminacy in the vegetative shoot apical meristem of angiosperms ([@bib22]), and are required for compound leaf formation in both tomato and *Cardamine hirsuta* ([@bib5]). In ferns, *KNOX* gene expression is observed both in the shoot apex and developing fronds ([@bib68]; [@bib3]), and in *P. patens* the genes regulate cell division patterns in the determinate sporophyte ([@bib67]). It can thus be speculated that *LFY* and *KNOX* had overlapping functions in the sporophyte of the last common ancestor of land plants, but by the divergence of ancestral angiosperms from gymnosperms, *KNOX* genes had come to dominate in vegetative meristems whereas *LFY* became increasingly specialized for floral meristem function. Unlike *LFY*, however, there is not yet any evidence for *KNOX* function in the gametophyte of any land plant lineage, and thus if a pathway for regulating stem cell activity was co-opted from the gametophyte into the sporophyte, the LFY pathway is the more likely one.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                Designation                          Source or reference          Identifiers                                                    Additional information
  (species) or resource                                                                                                                                         
  ---------------------------- ------------------------------------ ---------------------------- -------------------------------------------------------------- ---------------------------------------------------------------------
  Gene\                        *CrLEAFY1* (*CrLFY1*)                [@bib30],\                   NCBI:AB049974.2;\                                              cDNA only; ORF plus\
  (*Ceratopteris richardii*)                                        PMID:11675598;\              NCBI:MH841970                                                  contiguous promoter
                                                                    This paper                                                                                  

  Gene (*C. richardii*)        *CrLEAFY2* (*CrLFY2*)                [@bib30],\                   NCBI:AB049975.2;\                                              cDNA only; ORF plus\
                                                                    PMID:11675598;\              NCBI:MH841971                                                  contiguous promoter
                                                                    This paper                                                                                  

  Strain, strain\              Wild type (Hn-n)                     [@bib83],\                                                                                  
  background\                                                       PMID:16665325                                                                               
  (*C. richardii*)                                                                                                                                              

  Genetic reagent\             *CrLFY1/2-i1*                        This paper                                                                                  *C. richardii* transgenic line;\
  (*C. richardii*)                                                                                                                                              RNAi knockdown of *CrLFY1*\
                                                                                                                                                                and *CrLFY2* expression.

  Genetic reagent\             *CrLFY1/2-i2*                        This paper                                                                                  *C. richardii* transgenic line;\
  (*C. richardii*)                                                                                                                                              RNAi knockdown of *CrLFY1*\
                                                                                                                                                                and *CrLFY2* expression.

  Genetic reagent\             *CrLFY1-i3*                          This paper                                                                                  *C. richardii* transgenic line;\
  (*C. richardii*)                                                                                                                                              RNAi knockdown of *CrLFY1*\
                                                                                                                                                                expression.

  Genetic reagent\             *CrLFY2-i4*                          This paper                                                                                  *C. richardii* transgenic line;\
  (*C. richardii*)                                                                                                                                              RNAi knockdown of *CrLFY2*\
                                                                                                                                                                expression.

  Genetic reagent\             *CrLFY1~pro~::GUS*                   This paper                                                                                  C. richardii transgenic line;\
  (*C. richardii*)                                                                                                                                              *CrLFY1~pro~::GUS* reporter.

  Genetic reagent\             *35S~pro~::GUS*                      This paper                                                                                  C. richardii transgenic line;\
  (*C. richardii*)                                                                                                                                              *35S~pro~::GUS* reporter.

  Recombinant\                 *CrLFY1~pro~*                        This paper                   NCBI:MH841970                                                  CrLFY1 5\' genomic fragment;\
  DNA reagent                                                                                                                                                   [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}

  Recombinant\                 *CrLFY2~pro~* fragment 1             This paper                   NCBI:MH841971                                                  CrLFY2 5\' genomic fragment;\
  DNA reagent                                                                                                                                                   [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}

  Recombinant\                 *CrLFY2~pro~* fragment 2             This paper                                                                                  CrLFY2 5\' genomic fragment;\
  DNA reagent                                                                                                                                                   [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"};\
                                                                                                                                                                [Supplementary file 7](#supp7){ref-type="supplementary-material"}

  Recombinant\                 GUS                                  [@bib79],\                                                                                  Β-Glucuronidase (GUS)\
  DNA reagent                                                       PMID:9401121                                                                                coding sequence

  Recombinant\                 pANDA (RNAi vector)                  [@bib50],\                                                                                  
  DNA reagent                                                       PMID:15111724                                                                               

  Recombinant\                 pCR4-TOPO (Cloning vector)           Invitrogen                   Thermo Scientific:\                                            
  DNA reagent                                                                                    K457502                                                        

  Recombinant\                 pDONR207 (Gateway vector)            Invitrogen                                                                                  
  DNA reagent                                                                                                                                                   

  Recombinant\                 pBOMBER (Binary vector)              [@bib60],\                   NCBI:MH841969                                                  Modified pART27 (PMID:1463857);\
  DNA reagent                                                       PMID:26146510                                                                               Hygromycin resistance antibiotic\
                                                                                                                                                                selection marker

  Recombinant\                 pART7 (Cloning vector)               Gleave 1992,\                                                                               
  DNA reagent                                                       PMID:1463857                                                                                

  Recombinant\                 *ZmUbi~pro~::CrLFY1/2-i1-pANDA*      This paper                                                                                  RNAi construct targeting *CrLFY1*\
  DNA reagent                                                                                                                                                   and *CrLFY2*;\
                                                                                                                                                                [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"};\
                                                                                                                                                                [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}

  Recombinant\                 *ZmUbi~pro~::CrLFY1/2-i2-pANDA*      This paper                                                                                  RNAi construct targeting\
  DNA reagent                                                                                                                                                   *CrLFY1* and *CrLFY2*;\
                                                                                                                                                                [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"};\
                                                                                                                                                                [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}

  Recombinant\                 *ZmUbi~pro~::CrLFY1-i3-pANDA*        This paper                                                                                  RNAi construct targeting *CrLFY1*;\
  DNA reagent                                                                                                                                                   [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"};\
                                                                                                                                                                [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}

  Recombinant\                 *ZmUbi~pro~::CrLFY2-i4-pANDA*        This paper                                                                                  RNAi construct targeting CrLFY2;\
  DNA reagent                                                                                                                                                   [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"};\
                                                                                                                                                                [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}

  Recombinant\                 *CrLFY1~pro~::GUS-pBOMBER*           This paper                                                                                  GUS reporter construct, *CrLFY1*;\
  DNA reagent                                                                                                                                                   [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}

  Recombinant\                 *35Spro::GUS-pBOMBER*                This paper                                                                                  GUS reporter construct, *35S*\
  DNA reagent                                                                                                                                                   control; [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}

  Recombinant\                 *CrLFY1 in situ* probe (antisense)   This paper                                                                                  In situ hybridisation probe;\
  DNA reagent                                                                                                                                                   [Supplementary file 6](#supp6){ref-type="supplementary-material"}

  Recombinant\                 *CrLFY1 in situ* probe (sense)       This paper                                                                                  In situ hybridisation probe;\
  DNA reagent                                                                                                                                                   [Supplementary file 6](#supp6){ref-type="supplementary-material"}

  Recombinant\                 *CrLFY2 in situ* probe (antisense)   This paper                                                                                  In situ hybridisation probe;\
  DNA reagent                                                                                                                                                   [Supplementary file 6](#supp6){ref-type="supplementary-material"}

  Recombinant\                 *CrLFY2 in situ* probe (sense)       This paper                                                                                  In situ hybridisation probe;\
  DNA reagent                                                                                                                                                   [Supplementary file 6](#supp6){ref-type="supplementary-material"}

  Recombinant\                 ^32^P-CrLFY1 probe 1                 This paper                                                                                  DNA gel blot probe for\
  DNA reagent                                                                                                                                                   CrLFY1;\
                                                                                                                                                                [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}

  Recombinant\                 ^32^P-CrLFY1 probe 2                 This paper                                                                                  DNA gel blot probe for CrLFY1;\
  DNA reagent                                                                                                                                                   [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}

  Recombinant\                 ^32^P-CrLFY2 probe 1                 This paper                                                                                  DNA gel blot probe for CrLFY2;\
  DNA reagent                                                                                                                                                   [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}

  Recombinant\                 ^32^P-CrLFY2 probe 1                 This paper                                                                                  DNA gel blot probe for CrLFY2;\
  DNA reagent                                                                                                                                                   [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}

  Recombinant\                 ^32^P-HygR probe                     [@bib59],\                                                                                  DNA gel blot probe, T-DNA\
  DNA reagent                                                       PMID:24623851                                                                               specific; [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}

  Recombinant\                 ^32^P-GUS probe                      [@bib59],\                                                                                  DNA gel blot probe, T-DNA specific;\
  DNA reagent                                                       PMID:24623851                                                                               [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}

  Recombinant\                 ^32^P-GUSlinker probe                This paper                                                                                  DNA gel blot probe, T-DNA specific;\
  DNA reagent                                                                                                                                                   [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}

  Sequence-based\              CrLFY1ampF                           This paper                                                                                  ORF amplification,\
  reagent                                                                                                                                                       CrLFY1: 5\'-ATGGATGTCTCT\
                                                                                                                                                                TTATTGCCAC-3\'

  Sequence-based\              CrLFY1ampR                           This paper                                                                                  ORF amplification,\
  reagent                                                                                                                                                       CrLFY1: 5\'-TCAATCATAGATGC\
                                                                                                                                                                AGCTATCACTG-3\'

  Sequence-based\              CrLFY1ampF                           This paper                                                                                  ORF amplification,\
  reagent                                                                                                                                                       CrLFY2: 5\'-ATGTTCCGATGG\
                                                                                                                                                                GAACAAAG-3\'

  Sequence-based\              CrLFY1ampR                           This paper                                                                                  ORF amplification,\
  reagent                                                                                                                                                       CrLFY2: 5\'-TTATTCATAGCT\
                                                                                                                                                                GCAGCTGTC-3\'

  Sequence-based\              CrLFY1invF                           This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY1: 5\'-CTATGGAGTAC\
                                                                                                                                                                GAAGCACCAC-3\'

  Sequence-based\              CrLFY1invF2                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY1: 5\'-CGATCATTTCTT\
                                                                                                                                                                GTACTGCTCTC-3\'

  Sequence-based\              CrLFY1invF3                          This paper                                                                                  Inverse PCR, CrLFY1\
  reagent                                                                                                                                                       : 5\'-CAGTGCATGACCTTCGATATTG-3\'

  Sequence-based\              CrLFY1invR                           This paper                                                                                  Inverse PCR, CrLFY1:\
  reagent                                                                                                                                                       5\'-CAGTTGTTTCGGATCTGCAG-3\'

  Sequence-based\              CrLFY1invR2                          This paper                                                                                  Inverse PCR, CrLFY1:\
  reagent                                                                                                                                                       5\'-CTCCGCTTTTCATTTGAGAACG-3\'

  Sequence-based\              CrLFY1invR3                          This paper                                                                                  Inverse PCR, CrLFY1:\
  reagent                                                                                                                                                       5\'-CAAGAACCGCTGGAGTAAAC-3\'

  Sequence-based\              CrLFY2invF                           This paper                                                                                  Inverse PCR, CrLFY2:\
  reagent                                                                                                                                                       5\'-CTATGGTGTACGGAGCACTAC-3\'

  Sequence-based\              CrLFY2invF2                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CGTATCCAAAACAGC\
                                                                                                                                                                TTAAACTCC-3\'

  Sequence-based\              CrLFY2invF3                          This paper                                                                                  Inverse PCR, CrLFY2:\
  reagent                                                                                                                                                       5\'-CACTAAAGGTGCTGCTATCAAC-3\'

  Sequence-based\              CrLFY2invF4                          This paper                                                                                  Inverse PCR, CrLFY2:\
  reagent                                                                                                                                                       5\'-CATTGTGCTGACCTTGTGAAG-3\'

  Sequence-based\              CrLFY2invF5                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CGCAAAGGTTGGAA\
                                                                                                                                                                AAGAGAAC-3\'

  Sequence-based\              CrLFY2invF6                          This paper                                                                                  Inverse PCR, CrLFY2:\
  reagent                                                                                                                                                       5\'-CGACAACGGATCATAACCATC-3\'

  Sequence-based\              CrLFY2 invF7                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CAATAGTAGATT\
                                                                                                                                                                CTCCCTCCTTTAC-3\'

  Sequence-based\              CrLFY2invF8                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-GCTCTTTAATTT\
                                                                                                                                                                GAATCACGTGTG-3\'

  Sequence-based\              CrLFY2invF9                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-GAACAATGTGCA\
                                                                                                                                                                TGCGACTC-3\'

  Sequence-based\              CrLFY2invF10                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CATGTTCCGAT\
                                                                                                                                                                GGGAACAAAG-3\'

  Sequence-based\              CrLFY2invF11                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CATAGGGAACT\
                                                                                                                                                                CTGTAATGATGC-3\'

  Sequence-based\              CrLFY2invF12                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-GTTTCCAG\
                                                                                                                                                                ATACTGCTGCTC-3\'

  Sequence-based\              CrLFY2invF13                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CATAGATGA\
                                                                                                                                                                TGCCAGTATACTCC-3\'

  Sequence-based\              CrLFY2invF14                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-GCTCACTAT\
                                                                                                                                                                CCACAATTCATACAC-3\'

  Sequence-based\              CrLFY2invF15                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-GTTCGTATCT\
                                                                                                                                                                GATACTTGTTTCGTG-3\'

  Sequence-based\              CrLFY2invF16                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CTTACTCCA\
                                                                                                                                                                CGAATGCATGC-3\'

  Sequence-based\              CrLFY2invR                           This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CAGTTGTCAC\
                                                                                                                                                                AGAGGTAGCAG-3\'

  Sequence-based\              CrLFY2invR2                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CCTTACGATG\
                                                                                                                                                                TATTACCCTTTGTTC-3\'

  Sequence-based\              CrLFY2invR3                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CAGTGACTA\
                                                                                                                                                                GGATGTCTGATACAG-3\'

  Sequence-based\              CrLFY2invR4                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-GAAGGAGCT\
                                                                                                                                                                GAAAATGCAACTC-3\'

  Sequence-based\              CrLFY2invR5                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CCTGCCTCC\
                                                                                                                                                                TATGAAAACAC-3\'

  Sequence-based\              CrLFY2invR6                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CCTGTAAAGG\
                                                                                                                                                                AGGGAGAATCTAC-3\'

  Sequence-based\              CrLFY2invR7                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-GCACTCCAAC\
                                                                                                                                                                GATGATGATAC-3\'

  Sequence-based\              CrLFY2invR8                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-GCTGTACTA\
                                                                                                                                                                AGGCATCAATTCAG-3\'

  Sequence-based\              CrLFY2invR9                          This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CATCTATGATA\
                                                                                                                                                                GCACAACATCACTC-3\'

  Sequence-based\              CrLFY2invR10                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CACAACATC\
                                                                                                                                                                ACTCAGGACTC-3\'

  Sequence-based\              CrLFY2invR11                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CTGCCTCCTA\
                                                                                                                                                                TGAAAACACAAG-3\'

  Sequence-based\              CrLFY2invR12                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CTAGTCTTTG\
                                                                                                                                                                ATGAGGTTTCATGTC-3\'

  Sequence-based\              CrLFY2invR13                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CATGCAAGA\
                                                                                                                                                                AGCATGCAATTC-3\'

  Sequence-based\              CrLFY2invR14                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-GTGTCTCCA\
                                                                                                                                                                GTAAGTATGAAACAAG-3\'

  Sequence-based\              CrLFY2invR15                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CATGAGGCC\
                                                                                                                                                                GTCAGACTTAC-3\'

  Sequence-based\              CrLFY2invR16                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CGTAACAGA\
                                                                                                                                                                CGAGCTCGATATAATAG-3\'

  Sequence-based\              CrLFY2invR17                         This paper                                                                                  Inverse PCR,\
  reagent                                                                                                                                                       CrLFY2: 5\'-CTCTTTGCTCA\
                                                                                                                                                                TATAGCTTCAAGC-3\'

  Sequence-based\              CrLFY1 + 2 (1)-RNAi-F                This paper                                                                                  T-DNA cloning,\
  reagent                                                                                                                                                       CrLFY1/2-i1: 5\'-ATGGGT\
                                                                                                                                                                TTCACTGTGAATAC-3\'

  Sequence-based\              CrLFY1 + 2 (1)-RNAi-R                This paper                                                                                  T-DNA cloning,\
  reagent                                                                                                                                                       CrLFY1/2-i1: 5\'-TCTCCTC\
                                                                                                                                                                TTTGTTCCCTTGTG-3\'

  Sequence-based\              CrLFY1 + 2 (2)-RNAi-F                This paper                                                                                  T-DNA cloning,\
  reagent                                                                                                                                                       CrLFY1/2-i2: 5\'-ATGGG\
                                                                                                                                                                TTTCACTGTTAGTAC-3\'

  Sequence-based\              CrLFY1 + 2 (2)-RNAi-R                This paper                                                                                  T-DNA cloning,\
  reagent                                                                                                                                                       CrLFY1/2-i2: 5\'-TCTCCT\
                                                                                                                                                                CTTTGTTCCCTGGTG-3\'

  Sequence-based\              CrLFY1-RNAi-F                        This paper                                                                                  T-DNA cloning,\
  reagent                                                                                                                                                       CrLFY1-i3: 5\'-CCTTTTCT\
                                                                                                                                                                TGCTAATGATGGC-3\'

  Sequence-based\              CrLFY1-RNAi-R                        This paper                                                                                  T-DNA cloning,\
  reagent                                                                                                                                                       CrLFY1-i3: 5\'-CAAACAAA\
                                                                                                                                                                CTTGAAAATGATAC-3\'

  Sequence-based\              CrLFY2-RNAi-F                        This paper                                                                                  T-DNA cloning,\
  reagent                                                                                                                                                       CrLFY2-i4: 5\'-GCCATTG\
                                                                                                                                                                CTAGCAAGGTTAT-3\'

  Sequence-based\              CrLFY2-RNAi-R                        This paper                                                                                  T-DNA cloning,\
  reagent                                                                                                                                                       CrLFY2-i4: 5\'-CACTGCT\
                                                                                                                                                                TTGAAACTAAAAC-3\'

  Sequence-based\              pCrLFY1amp-NotF                      This paper                                                                                  T-DNA cloning,\
  reagent                                                                                                                                                       CrLFY1~pro~: 5\'-CAGCGGCCGCTTAGATGG\
                                                                                                                                                                CTTGAGATGCTAC-3\'

  Sequence-based\              pCrLFY1amp-XbaR                      This paper                                                                                  T-DNA cloning,\
  reagent                                                                                                                                                       CrLFY1~pro~: 5\'-CATCTAGAG\
                                                                                                                                                                GAGGCACTTCTTTACGTG-3\'

  Sequence-based\              GUSamp-XbaF                          This paper                                                                                  T-DNA cloning,\
  reagent                                                                                                                                                       GUS CDS: 5\'-CATCTAGAC\
                                                                                                                                                                AATGGTAAGCTTAGCGGG-3\'

  Sequence-based\              GUSamp-XbaR                          This paper                                                                                  T-DNA cloning,\
  reagent                                                                                                                                                       GUS CDS: 5\'-CCATCTAGA\
                                                                                                                                                                TTCATTGTTTGCCTCCCTG-3\'

  Sequence-based\              qCrLFY1_F2                           This paper                                                                                  qRT-PCR,\
  reagent                                                                                                                                                       CrLFY1: 5\'-GTCCGCT\
                                                                                                                                                                ATTCGTGCAGAGA-3\'

  Sequence-based\              qCrLFY1_R2                           This paper                                                                                  qRT-PCR, CrLFY1\
  reagent                                                                                                                                                       : 5\'-AATTCAAGGGGG\
                                                                                                                                                                CATTGGGT-3\'

  Sequence-based\              qCrLFY2_F3                           This paper                                                                                  qRT-PCR, CrLFY2:\
  reagent                                                                                                                                                       5\'-GCAGTGACAATGAAGGACGC-3\'

  Sequence-based\              qCrLFY2_R3                           This paper                                                                                  qRT-PCR, CrLFY2:\
  reagent                                                                                                                                                       5\'-AGAATCGTGCACACTGCTCA-3\'

  Sequence-based\              qCrTBPb_F                            [@bib23],\                                                                                  qRT-PCR, CrTBP:\
  reagent                                                           DOI:10.1139/cjb-2014--0202                                                                  5\'-ATGAGCCAGAGCTTTTCCCC-3\'

  Sequence-based\              qCrTBPb_R                            [@bib23],\                                                                                  qRT-PCR, CrTBP:\
  reagent                                                           DOI:10.1139/cjb-2014--0202                                                                  5\'-TTCGTCTCTGACCTTTGCCC-3\'

  Sequence-based\              qCrACT1_F                            [@bib23],\                                                                                  qRT-PCR,\
  reagent                                                           DOI:10.1139/cjb-2014--0202                                                                  CrActin1: 5\'-GAGAGAGGCTA\
                                                                                                                                                                CTCTTTCACAACC-3\'

  Sequence-based\              qCrACT1_R                            [@bib23],\                                                                                  qRT-PCR,\
  reagent                                                           DOI:10.1139/cjb-2014--0202                                                                  CrActin1: 5\'-AGGAAGTTCGTA\
                                                                                                                                                                ACTCTTCTCCAA-3\'

  Sequence-based\              CrLFY1_ISH_F                         This paper                                                                                  In situ probes,\
  reagent                                                                                                                                                       CrLFY1: 5\'-GAGGCATACA\
                                                                                                                                                                CACACGCAGT-3\'

  Sequence-based\              CrLFY1_ISH_R                         This paper                                                                                  In situ probes,\
  reagent                                                                                                                                                       CrLFY1: 5\'-TCAATCATAGAT\
                                                                                                                                                                GCAGCTATCACTG-3

  Sequence-based\              CrLFY2_ISH_F                         This paper                                                                                  In situ probes,\
  reagent                                                                                                                                                       CrLFY2: 5\'-GGCTGGTTGTTA\
                                                                                                                                                                CGGATAGC-3\'

  Sequence-based\              CrLFY2_ISH_R                         This paper                                                                                  In situ probes,\
  reagent                                                                                                                                                       CrLFY2: 5\'-TTATTCATAG\
                                                                                                                                                                CTGCAGCTGTCACTG-3\'

  Sequence-based\              CrLFY1_Probe1F                       This paper                                                                                  Copy number analysis,\
  reagent                                                                                                                                                       CrLFY1 probe 1: 5\'-CAGG\
                                                                                                                                                                CACAAGGGAACAAAG-3\'

  Sequence-based\              CrLFY1_Probe1R                       This paper                                                                                  Copy number analysis,\
  reagent                                                                                                                                                       CrLFY1 probe 1: 5\'-CA\
                                                                                                                                                                TAGATGCAGCTATCACTGTC-3\'

  Sequence-based\              CrLFY1_Probe2F                       This paper                                                                                  Copy number analysis,\
  reagent                                                                                                                                                       CrLFY1 probe 2:\
                                                                                                                                                                5\'-CACTTGAAGGTAAGCT\
                                                                                                                                                                TTATTGTAAGG-3\'

  Sequence-based\              CrLFY1_Probe2R                       This paper                                                                                  Copy number analysis,\
  reagent                                                                                                                                                       CrLFY1 probe 2: 5\'-CAATA\
                                                                                                                                                                TTTCCGACTATACATTGAGGC-3\'

  Sequence-based\              CrLFY2_Probe1F                       This paper                                                                                  Copy number analysis,\
  reagent                                                                                                                                                       CrLFY2 probe 1: 5\'-CAGGCA\
                                                                                                                                                                CCAGGGAACAAAG-3\'

  Sequence-based\              CrLFY2_Probe1R                       This paper                                                                                  Copy number analysis,\
  reagent                                                                                                                                                       CrLFY2 probe 1: 5\'-CATAGC\
                                                                                                                                                                TGCAGCTGGTCACTGTC-3\'

  Sequence-based\              CrLFY2_Probe2F                       This paper                                                                                  Copy number analysis,\
  reagent                                                                                                                                                       CrLFY2 probe 2: 5\'-CTGTAG\
                                                                                                                                                                AAGGTAAGATTCTGCTC-3\'

  Sequence-based\              CrLFY2_Probe2R                       This paper                                                                                  Copy number analysis,\
  reagent                                                                                                                                                       CrLFY2 probe 2: 5\'-GCTT\
                                                                                                                                                                ATGGTACAGAATAAGTAGAGG-3\'

  Sequence-based\              HygF2                                [@bib59],\                                                                                  T-DNA gel blot\
  reagent                                                           PMID:24623851                                                                               probe, Hyg^R^: 5\'-CTTCTACA\
                                                                                                                                                                CAGCCATCGGTC-3\'

  Sequence-based\              HygR                                 [@bib59],\                                                                                  T-DNA gel blot\
  reagent                                                           PMID:24623851                                                                               probe, Hyg^R^: 5\'-CCGATGGT\
                                                                                                                                                                TTCTACAAAGATCG-3\'

  Sequence-based\              GH3seqF3                             [@bib59],\                                                                                  T-DNA gel blot\
  reagent                                                           PMID:24623851                                                                               probe, GUS: 5\'-CTTCGCT\
                                                                                                                                                                GTACAGTTCTTTCG-3\'

  Sequence-based\              GH3seqR4                             [@bib59],\                                                                                  T-DNA gel blot\
  reagent                                                           PMID:24623851                                                                               probe, GUS: 5\'-CACTCATT\
                                                                                                                                                                ACGGCAAAGTGTG-3\'

  Sequence-based\              GUSlinkerseqF                        This paper                                                                                  T-DNA gel blot\
  reagent                                                                                                                                                       probe, RNAi: 5\'-CTGATT\
                                                                                                                                                                AACCACAAACCGTTCTAC-3\'

  Sequence-based\              GUSlinkerseqR                        This paper                                                                                  T-DNA gel blot\
  reagent                                                                                                                                                       probe, RNAi: 5\'-CTGATA\
                                                                                                                                                                CTCTTCACTCCACATG-3\'

  Sequence-based\              HPT-F                                [@bib50],\                                                                                  RNAi genotyping,\
  reagent                                                           PMID:15111724                                                                               Hyg^R^: 5\'-GAGCCTGACCTA\
                                                                                                                                                                TTGCATCTCC-3\'

  Sequence-based\              HPT-R                                [@bib50],\                                                                                  RNAi genotyping,\
  reagent                                                           PMID:15111724                                                                               Hyg^R^: 5\'-GGCCTCCAG\
                                                                                                                                                                AAGAAGATGTTGG-3\'

  Sequence-based\              pVec8F                               [@bib50],\                                                                                  RNAi genotyping,\
  reagent                                                           PMID:15111724                                                                               RNAi hairpin: 5\'-TTTAGC\
                                                                                                                                                                CCTGCCTTCATACG-3\'

  Sequence-based\              pVec8R                               [@bib50],\                                                                                  RNAi genotyping,\
  reagent                                                           PMID:15111724                                                                               RNAi hairpin: 5\'-ATTGC\
                                                                                                                                                                CAAATGTTTGAACGA-3\'

  Sequence-based\              PW64F                                This paper                                                                                  RNAi genotyping,\
  reagent                                                                                                                                                       RNAi hairpin: 5\'-CATGAA\
                                                                                                                                                                GATGCGGACTTACG-3\'

  Sequence-based\              PW64R                                This paper                                                                                  RNAi genotyping,\
  reagent                                                                                                                                                       RNAi hairpin: 5\'-ATCCAC\
                                                                                                                                                                GCCGTATTCGG-3\'

  Sequence-based\              pCrLFY1genoF1                        This paper                                                                                  *CrLFY1~pro~::GUS*\
  reagent                                                                                                                                                       genotyping: 5\'-CTTAGA\
                                                                                                                                                                TGGCTTGAGATGCTAC-3\'

  Sequence-based\              pCrLFY1genoF2                        This paper                                                                                  *CrLFY1~pro~::GUS*\
  reagent                                                                                                                                                       genotyping: 5\'-CTCTCT\
                                                                                                                                                                TCTTGCTTGTGTTGTG-3\'

  Sequence-based\              pCrLFY1genoF3                        This paper                                                                                  *CrLFY1~pro~::GUS* genotyping:\
  reagent                                                                                                                                                       5\'-CAACTGGCAACAGGTGATG-3\'

  Sequence-based\              pCrLFY1genoF4                        This paper                                                                                  *CrLFY1~pro~::GUS* genotyping:\
  reagent                                                                                                                                                       5\'-CAGTCTTAGTTCAACTGCATTCG-3\'

  Sequence-based\              pCrLFY1genoR                         This paper                                                                                  *CrLFY1~pro~::GUS* genotyping:\
  reagent                                                                                                                                                       5\'-AGGAGGCACTTCTTTACGTG-3\'

  Sequence-based\              GUSgenoR                             This paper                                                                                  *CrLFY1~pro~::GUS + 35S~pro~::GUS*\
  reagent                                                                                                                                                       genotyping: 5\'-CATTGTTTG\
                                                                                                                                                                CCTCCCTGC-3\'

  Sequence-based\              35SgenoF                             This paper                                                                                  *35S~pro~::GUS* genotyping:\
  reagent                                                                                                                                                       5\'-CTGAGCTTAACAGCACAGTTG-3\'

  Sequence-based\              OCS3'genoR                           This paper                                                                                  *35S~pro~::GUS* genotyping:\
  reagent                                                                                                                                                       5\'-CATCACTAGTAAGCTAGCTTGC-3\'

  Commercial\                  Phusion high-fidelity\               Thermo Scientific            Thermo Scientific:\                                            
  assay or kit                 polymerase                                                        F530S                                                          

  Commercial\                  Gateway LR clonase\                  Invitrogen                   Thermo Scientific:\                                            
  assay or kit                 II enzyme mix                                                     11791100                                                       

  Commercial\                  QIAGEN Plasmid\                      QIAGEN                       QIAGEN:12163                                                   
  assay or kit                 Maxi Kit                                                                                                                         

  Commercial\                  Whatman Nytran\                      GE Healthcare                GE Healthcare:\                                                
  assay or kit                 nylon blotting membrane                                           10416294                                                       

  Commercial\                  Random Primers\                      Invitrogen                   Thermo Scientific:\                                            
  assay or kit                 DNA Labelling kit                                                 18187013                                                       

  Commercial\                  Carestream Kodak\                    Sigma-Aldrich                Sigma-Aldrich:\                                                
  assay or kit                 autoradiography GBX\                                              Z354147                                                        
                               developer and fixer                                                                                                              

  Commercial\                  Carestream Kodak\                    Sigma-Aldrich                Sigma-Aldrich:F5763                                            
  assay or kit                 Biomax XAR film                                                                                                                  

  Commercial\                  iTaq universal SYBR\                 Bio-Rad                      Bio-Rad:1725120                                                
  assay or kit                 Green mastermix                                                                                                                  

  Commercial\                  DIG-labelling mix                    Roche Applied Sciences       Roche:11277073910                                              
  assay or kit                                                                                                                                                  

  Commercial\                  T3 RNA polymerase                    Roche Applied Sciences       Roche:11031163001                                              
  assay or kit                                                                                                                                                  

  Commercial\                  T7 RNA polymerase                    Roche Applied Sciences       Roche:10881767001                                              
  assay or kit                                                                                                                                                  

  Commercial\                  Anti-DIG antibody                    Roche Applied Sciences       Roche:11093274910;\                                            
  assay or kit                                                                                   RRID:[AB_2313639](https://scicrunch.org/resolver/AB_2313639)   

  Commercial\                  NBT/BCIP stock solution              Roche Applied Sciences       Roche:11681451001                                              
  assay or kit                                                                                                                                                  

  Chemical\                    Potassium ferricyanide\              Sigma-Aldrich                Sigma:P8131                                                    
  compound, drug               (K₃Fe(CN)₆)                                                                                                                      

  Chemical\                    X-GlcA (CHA salt)                    Melford Scientific           Melford:MB1021                                                 
  compound, drug                                                                                                                                                

  Chemical\                    CTP, \[ɑ-^32^P\]                     Perkin Elmer                 Perkin Elmer:\                                                 
  compound, drug                                                                                 BLU008H250UC                                                   

  Software,\                   IQ-TREE                              [@bib56],\                                                                                  <http://www.iqtree.org/>
  algorithm                                                         PMID:25371430                                                                               

  Software,\                   iTOL                                 [@bib40],\                                                                                  <https://itol.embl.de/>
  algorithm                                                         PMID:27095192                                                                               

  Software,\                   ClustalW                             [@bib41],\                   RRID:[SCR_002909](https://scicrunch.org/resolver/SCR_002909)   <https://www.ebi.ac.uk/Tools/msa/clustalw2/>
  algorithm                                                         PMID:25845596                                                                               

  Software,\                   TBLASTX                              [@bib2],\                    RRID:[SCR_011823](https://scicrunch.org/resolver/SCR_011823)   <https://blast.ncbi.nlm.nih.gov/Blast.cgi>
  algorithm                                                         PMID:2231712                                                                                

  Software,\                   GeneWise                             [@bib8],\                    RRID:[SCR_015054](https://scicrunch.org/resolver/SCR_015054)   <https://www.ebi.ac.uk/Tools/psa/genewise>
  algorithm                                                         PMID:15123596                                                                               

  Software,\                   GraphPad Prism                       GraphPad Software Inc.       RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)   <https://www.graphpad.com/scientific-software/prism/>
  algorithm                                                                                                                                                     

  Software,\                   Adobe Photoshop CS4                  Adobe                        RRID:[SCR_014199](https://scicrunch.org/resolver/SCR_014199)   
  algorithm                                                                                                                                                     

  Other                        Biolistic PDS-1000/He\               Bio-Rad                      Bio-Rad:1652257                                                
                               Particle Delivery System                                                                                                         

  Other                        CFX Connect Real-Time\               Bio-Rad                      Bio-Rad:1855201                                                
                               PCR Detection System                                                                                                             

  Other                        Zeiss Axioplan microscope            Zeiss                                                                                       

  Other                        Nikon Microphot-FX\                  Nikon                                                                                       
                               microscope                                                                                                                       

  Other                        MicroPublisher\                      Qimaging                                                                                    
                               3.3 RTV camera                                                                                                                   
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Plant materials and growth conditions {#s4-1}
-------------------------------------

All experimental work was conducted using *Ceratopteris richardii* strain Hn-n ([@bib83]). Plant growth conditions for Ceratopteris transformation and DNA gel blot analysis of transgenic lines were as previously described ([@bib60]).

Phylogenetic analysis {#s4-2}
---------------------

A dataset of 99 aligned LFY protein sequences from a broad range of streptophytes was first retrieved from [@bib69]. The dataset was pruned and then supplemented with further sequences ([Supplementary file 1](#supp1){ref-type="supplementary-material"}) to enable trees to be inferred that would (i) provide a more balanced distribution across the major plant groups and (ii) infer fern relationships. Only a subset of available angiosperm sequences was retained (keeping both monocot and dicot representatives) but protein sequences from other angiosperm species where function has been defined through loss-of-function analyses were added from NCBI -- *Antirrhinum majus* FLO AAA62574.1 ([@bib20]), *Pisum sativum* UNI AAC49782.1 ([@bib31]), *Cucumis sativus* CsLFY XP_004138016.1 ([@bib92]), *Medicago truncatula* SGL1 AY928184 ([@bib82]), *Petunia hybrida* ALF AAC49912.1 ([@bib73]), *Nicotiana tabacum* NFL1 AAC48985.1 and NFL2 AAC48986.1 ([@bib37]), *Eschscholzia californica* EcFLO AAO49794.1 ([@bib14]), *Gerbera hybrida* cv. 'Terraregina' GhLFY ANS10152.1 ([@bib91]), *Lotus japonicus* LjLFY AAX13294.1 ([@bib21]) and *Populus trichocarpa* PTLF AAB51533.1 ([@bib66]). To provide better resolution within and between angiosperm clades, sequences from *Spirodela polyrhiza* (32G0007500), *Zostera marina* (27g00160.1), *Aquilegia coerulea* (5G327800.1) and *Solanum tuberosum* (PGSC0003DMT400036749) were added from Phytozome v12.1 (<https://phytozome.jgi.doe.gov/pz/portal.html>). Genome sequence from the early-diverging Eudicot *Thalictrum thalictroides* was searched by TBLASTX ([@bib2]) (<https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=tblastx&PAGE_TYPE=BlastSearch&BLAST_SPEC=&LINK_LOC=blasttab>) with nucleotide sequence from the Arabidopsis *LFY* gene. A gene model was derived from sequence in two contigs (108877 and 116935) using Genewise ([@bib8]) (<https://www.ebi.ac.uk/Tools/psa/genewise/>). Gymnosperm sequences were retained from *Ginkgo biloba* and from a subset of conifers included in [@bib69], whilst sequences from conifers where *in situ* hybridization patterns have been reported were added from NCBI -- *Pinus radiata* PRFLL AAB51587.1 and NLY AAB68601.1 ([@bib47]; [@bib53]) and *Picea abies* PaLFY AAV49504.1 and PaNLY AAV49503.1 ([@bib15]). Fern sequences were retained except *Angiopteris spp* sequences which consistently disrupted the topology of the tree by grouping with gymnosperms. To better resolve relationships within the ferns, additional sequences were identified in both NCBI and 1KP ([@bib46]) databases. The protein sequence from *Matteuccia struthiopteris* AAF77608.1 MatstFLO ([@bib30]) was retrieved from NCBI. Further sequences from horsetails (2), plus eusporangiate (1) and leptosporangiate (53) ferns were retrieved from the 1KP database (<https://db.cngb.org/blast/>) using BLASTP and the MatstFLO sequence as a query. Lycophyte and bryophyte sequences were all retained, but the liverwort *Marchantia polymorpha* predicted ORF sequence was updated from Phytozome v12.1 (Mpo0113s0034.1.p), the hornwort *Nothoceros* genome scaffold was replaced with a translated full length cDNA sequence (AHJ90704.1) from NCBI and two additional lycophyte sequences were added from the 1KP dataset (*Isoetes tegetiformans* scaffold 2013584 and *Selaginella kraussiana* scaffold 2008343). All of the charophyte scaffold sequences were substituted with *Coleochaete scutata* (AHJ90705.1) and *Klebsormidium subtile* (AHJ90707.1) translated full-length cDNAs from NCBI.

The new/replacement sequences were trimmed and amino acids aligned to the existing alignment from [@bib69] using CLUSTALW ([@bib41]) ([Supplementary file 2](#supp2){ref-type="supplementary-material"} and [3](#supp3){ref-type="supplementary-material"}). The best-fitting model parameters (JTT + I + G4) were estimated and consensus phylogenetic trees were run using Maximum Likelihood from 1000 bootstrap replicates, using IQTREE ([@bib56]). Two trees were inferred. The first contained only a subset of fern and allied sequences to achieve a more balanced distribution across the major plant groups (81 sequences in total) ([Figure 8](#fig8){ref-type="fig"}), whereas the second used the entire dataset (120 sequences \~ 50% of which are fern and allied sequences -- [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). The data were imported into ITOL ([@bib40]) to generate the pictorial representations. All branches with less than 50% bootstrap support were collapsed. Relationships within the ferns ([Figure 1](#fig1){ref-type="fig"}) were represented by pruning the lycophyte and fern sequences (68 in total) from the tree containing all available fern sequences (**[Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).**

*CrLFY* locus characterization and DNA gel blot analysis {#s4-3}
--------------------------------------------------------

Because no reference genome has yet been established for Ceratopteris (or any fern), *CrLFY* copy number was quantified by DNA gel blot analysis. Ceratopteris genomic DNA was hybridized using both the highly conserved LFY DNA-binding domain diagnostic of the *LFY* gene family ([@bib45]) and also gene copy-specific sequences ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). CrLFY1 and CrLFY2 share 85% amino acid similarity, compared to 65% and 44% similarity of each to AtLFY. DNA gel blotting and hybridization was performed as described previously ([@bib59]). The results supported the presence of only two copies of *LFY* within the Ceratopteris genome. All primers used in probe preparation are supplied in the Key Resources Table.

Genomic sequences for *CrLFY1* and *CrLFY2* open reading frames (ORFs) were amplified by PCR from wild-type genomic DNA using primers designed against published transcript sequences ([@bib30]). ORFs of 1551 bp and 2108 bp were obtained, respectively ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Exon structure was determined by comparison between genomic and transcript sequences. The native promoter region of *CrLFY1* was amplified from genomic template by sequential rounds of inverse PCR with initial primer pairs designed against published *CrLFY1* 5'UTR sequence and additional primers subsequently designed against additional contiguous sequence that was retrieved. A 3.9 kb contiguous promoter fragment was isolated for *CrLFY1* containing the entire published 5'UTR and 1.9 kb of additional upstream sequence ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Repeated attempts were made to obtain a *CrLFY2* promoter fragment but this proved impossible in the absence of a reference genome. Some sequence contiguous with the *CrLFY2* ORF was obtained by inverse PCR using primers designed against the previously published 5'UTR sequence of the *CrLFY2* transcript ([@bib30]). This sequence was extended to 1016 bp in length using additional primers against the isolated genomic sequence but this fragment did not contain the entire published 5'UTR. Numerous rounds of inverse PCR generated a second 3619 bp genomic fragment containing sequence identical to the remaining 5'UTR (see [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, [Supplementary file 7](#supp7){ref-type="supplementary-material"}) but the presumed connecting sequence between these two fragments could not be amplified despite many attempts. It was eventually concluded that either the intervening promoter fragment was too long to amplify or that it was too GC rich for amplification. All primers used in ORF amplification and inverse PCR are supplied in the Key Resources table. The contiguous sequences obtained for the *CrLFY1* and *CrLFY2* genomic loci have been submitted to Genbank (accessions MH841970 and MH841971, respectively).

qRT-PCR analysis of gene expression {#s4-4}
-----------------------------------

RNA was extracted from Ceratopteris tissues using the Spectrum Total Plant RNA kit (Sigma-Aldrich, St. Louis, MO) and 480 ng were used as template in iScript cDNA synthesis (Bio-Rad). *CrLFY1* and *CrLFY2* locus-specific qRT-PCR primers were designed spanning intron 1. Amplification specificity of primers was validated via PCR followed by sequencing. qRT-PCR of three biological replicates and three technical replicates each was performed in a Bio-Rad CFX Connect with iTaq Universal SYBR Green Supermix (Bio-Rad, Hercules, CA). Primer amplification efficiency was checked with a cDNA serial dilution. Efficiency was determined using the slope of the linear regression line as calculated by Bio-Rad CFX Connect software. Primer specificity was tested via melting curve analysis, resulting in a single peak per primer set. *CrLFY* expression was calculated using the 2^-\ ΔΔCt^ method ([@bib43]) and normalized against the geometric mean of the expression of two endogenous reference genes ([@bib27]), *CrACTIN1* and *CrTATA-BINDING PROTEIN (TBP)* ([@bib23]). The standard deviation of the Ct values of each reference gene was calculated to ensure minimal variation (\<3%) in gene expression. Error bars represent ± the standard error of the mean of the 2 ^ΔΔ\ Ct^ values. All primers used in qRT-PCR are supplied in the Key Resources table.

Relative expression values of *CrLFY* from qRT-PCR were compared by one or two-way analysis of variance (ANOVA) for developmental stages followed by Tukey's or Sidak's multiple comparisons, respectively. To test whether genes were downregulated in transgenic RNAi lines, two-way ANOVA was perfomed with gene (*CrLFY1* or *CrLFY2*) and transgenic line as factors, with 'gene' as a repeated factor when all transgenic lines had the same number of replicates. Where appropriate, expression of each gene in each line was compared to the expression of the respective control by Dunnet comparisons. Control plants had been transformed and were hygromycin-resistant, but did not contain the RNAi hairpin that triggers gene silencing (non-hairpin controls, NHC). For all experiments, NHCs were grown alongside transgenic lines. qRT-PCR of transgenic lines was necessarily conducted across several plates, each including a representative NHC, and statistical comparisons were performed within each plate relative to its respective control. The significance threshold (p) was set at 0.05. All statistical analyses were performed in Prism v. 6.0 (GraphPad Software, Inc., La Jolla, CA).

Generation of GUS reporter constructs {#s4-5}
-------------------------------------

The *CrLFY1~pro~::GUS* reporter construct ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) was created by cloning the *CrLFY1* promoter into pART7 as a *Not*I-*Xba*I restriction fragment, replacing the existing *35S* promoter. A β-Glucuronidase (GUS) coding sequence ([@bib79]) was cloned downstream of *pCrLFY1* as an *Xba*I-*Xba*I fragment. The same GUS *Xba*I-*Xba*I fragment was also cloned into pART7 to create a *35S~pro~::GUS* positive control ([Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}). The resulting *CrLFY1~pro~::GUS::ocs* and *35S~pro~::GUS::ocs* cassettes were each cloned as *Not*I-*Not*I fragments into the pART27-based binary transformation vector pBOMBER carrying a hygromycin resistance marker previously optimized for Ceratopteris transformation ([@bib60]). All primers used in GUS reporter component amplification are supplied in the Key Resources table.

Generation of RNAi constructs {#s4-6}
-----------------------------

RNAi constructs were designed and constructed using the pANDA RNAi expression system ([@bib50]). Four RNAi fragments were designed, two targeting a conserved region of the *CrLFY1* and *CrLFY2* coding sequence (77% nucleotide identity) using sequences from either *CrLFY1* (*CrLFY1/2-i1*) or *CrLFY2* (*CrLFY1/2-i2*), and two targeting gene-specific sequence within the 3'UTR of *CrLFY1* (*CrLFY1-i3*) or *CrLFY2* (*CrLFY2-i4*) ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Target fragments were amplified from cDNA and cloned into Gateway-compatible entry vector pDONR207 (Invitrogen, Carlsbad, CA). Each sequence was then recombined into the pANDA expression vector via Gateway LR cloning (Invitrogen, Carlsbad, CA). All primers used in RNAi target fragment amplification are supplied in the Key Resources table.

Generation of transgenic lines {#s4-7}
------------------------------

Transformation of all transgenes into wild-type Hn-n Ceratopteris callus was performed as previously described ([@bib60]). T~0~ sporophyte shoots were regenerated from transformed callus tissue, with each round of transformation using multiple separate pieces of callus as starting material. Transgenic T~1~ spores were harvested from these T~0~ shoots, germinated to form T~1~ gametophytes and then self-fertilized to produce T~1~ sporophytes. T~1~ sporophytes were assessed for T-DNA copy number by DNA gel blot analysis ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}; [Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}) and the presence of full-length T-DNA insertions was confirmed through genotyping PCR ([Figure 4---figure supplements 3](#fig4s3){ref-type="fig"} and [4](#fig4s4){ref-type="fig"}). All primers used in genotyping reactions are supplied in the Key Resources table. For characterization of RNAi lines, T~2~ spores were collected from individuals that either contained the full transgene construct or from segregants in which the RNAi hairpin was absent.

GUS staining {#s4-8}
------------

GUS activity analysis in *CrLFY1~pro~::GUS* transgenic lines was conducted in the T~1~ generation. GUS staining was conducted as described previously ([@bib59]). Optimum staining conditions (1 mg/ml X-GlcA, 5 μM potassium ferricyanide) were determined empirically. Tissue was cleared with sequential incubations in 70% ethanol until no further decolorization occurred. GUS-stained gametophytes were imaged with a Zeiss Axioplan microscope and GUS-stained sporophytes imaged with a dissecting microscope, both mounted with Q-imaging Micro-published 3.3 RTV cameras. Images were minimally processed for brightness and contrast in Photoshop (CS4).

Phenotypic characterization {#s4-9}
---------------------------

Phenotypic characterization of RNAi transgenic lines was conducted in the T~2~ or T~3~ generation. Isogenic lines were obtained by isolating hermaphrodite gametophytes in individual wells at approximately 7 DPS (or when the notch became visible, whichever came first) and flooding them once they had developed mature gametangia (at approximately 9 DPS). All transgenic lines were grown alongside both wild-type and no hairpin controls, and phenotypes observed and recorded daily. Gametophytes exhibiting altered phenotypes were imaged at approximately 10 DPS with a Nikon Microphot-FX microscope. Sporophytes with abnormal phenotypes were imaged with a dissecting microscope.

*In situ* hybridization {#s4-10}
-----------------------

Antisense and sense RNA probes for *CrLFY1* and *CrLFY2* were amplified and cloned into pCR 4-TOPO (Invitrogen) and DIG-labelled according to the manufacturer's instructions (Roche, Indianapolis, IN). Probes were designed to include the 5'UTR and ORF (*CrLFY1* 521 bp 5'UTR and 1113 bp ORF; *CrLFY2* 301 bp 5'UTR and 1185 bp ORF) ([Supplementary file 6](#supp6){ref-type="supplementary-material"}). All primers used in *in situ* probe amplification are supplied in the Key Resources table. We were unable to identify fragments that distinguished the two genes in whole mount in situ hybridizations. Tissue was fixed in FAA (3.7% formaldehyde, 5% acetic acid; 50% ethanol) for 1--4 hr and then stored in 70% ethanol. Whole mount *in situ* hybridization was carried out based on [@bib26], with the following modifications: hybridization and wash steps were carried out in 24-well plates with custom-made transfer baskets (0.5 mL microcentrifuge tubes and 30 µm nylon mesh, Small Parts Inc., Logansport, IN). Permeabilization and post-fixation steps were omitted depending on tissue type to avoid damaging fragile gametophytes, Acetic Anhydride (Sigma-Aldrich) and 0.5% Blocking Reagent (Roche) washing steps were added to decrease background staining, and tissue was hybridized at 45°C. Photos were taken under bright-field with a Q-imaging Micro-publisher 3.3 RTV camera mounted on a Nikon Microphot-FX microscope. Images were minimally processed for brightness and contrast in Photoshop (CS4).
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###### LFY sequences included in phylogenetic analysis (in addition to [@bib69]) dataset).

10.7554/eLife.39625.028

###### Alignment of all 120 LFY amino acid sequences used in phylogenetic analysis.

10.7554/eLife.39625.029

###### Alignment of LFY amino acid sequences used in phylogenetic analysis (ferns only).

10.7554/eLife.39625.030

###### Statistical comparison of *CrLFY* transcript levels between different ontogenetic stages.

10.7554/eLife.39625.031

###### Specificity of *CrLFY* RNAi target sequences.

Alignment (prepared using Clustal Omega) of the full length transcript sequences for *CrLFY1* and *CrLFY2*, with nucleotide identity between the two gene copies denoted by a subtending asterisk. The CDS for each gene is highlighted in bold. The target sequences for each RNAi construct are highlighted in light blue (*CrLFY1/2-i1*), light green (*CrLFY1/2-i2*), dark blue (*CrLFY1-i3*) or dark green (*CrLFY2-i4*). The *CrLFY1/2-i1* and *CrLFY1/2-i2* target sequences each have 77% similarity to the opposing gene transcript (BLAST2n, discontiguous megablast for highly similar sequences). The full-length *CrLFY1-i3* and *CrLFY2-i4* target sequences do not demonstrate significant sequence similarity to the opposing gene transcript or 3'UTR alone (BLAST2n, blastn for somewhat similar sequences) but short regions of similarity within the target sequence might explain the cross-reactivity observed.

10.7554/eLife.39625.032

###### Predicted hybridization and specificity of *CrLFY in situ* hybridization probes.

Alignment (prepared using Clustal Omega) of full length *CrLFY1* and *CrLFY2* transcript sequences, with nucleotide identity between the two paralogs denoted by a subtending asterisk. The coding sequence (CDS) for each gene copy is highlighted in bold. Predicted sites of hybridization for the two probes are highlighted in blue (*CrLFY1*) and yellow (*CrLFY2*) respectively, with PCR primer sites underlined. The in situ probes span the complete CDS and 5'UTR of each gene copy. The *CrLFY1* probe sequence shows 79% nucleotide identity to the *CrLFY2* transcript (BLAST2n, discontiguous megablast for highly similar sequences). The *CrLFY2* probe shows 79% nucleotide identity to the *CrLFY1* transcript (BLAST2n, discontiguous megablast for highly similar sequences).

10.7554/eLife.39625.033

###### Amplified *CrLFY2* genomic fragment (3619 bp), not connected directly to *CrLFY2* open reading frame.

Sequence highlighted in green corresponds to published *CrLFY2* 5'UTR ([@bib30])

10.7554/eLife.39625.034

###### Summary of published reports of LFY function in a range of angiosperm species.

All citations included in reference list of main article ([@bib12]; [@bib9]; [@bib13]; [@bib39]; [@bib61]; [@bib65]; [@bib24]; [@bib10]; [@bib6]; [@bib49]; [@bib74]; [@bib88]).

10.7554/eLife.39625.035

Data availability {#s7}
-----------------

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 3 and 6. Sequences and alignments for phylogenetic analyses are included in Supplementary files 1-3.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: this article was originally rejected after discussions between the reviewers, but the authors were invited to resubmit after an appeal against the decision.\]

Thank you for submitting your work entitled \"*LEAFY* maintains apical stem cell activity during shoot development in the fern *Ceratopteris richardii*\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The reviewers have opted to remain anonymous.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered for publication in *eLife* in its present form.

The reviewers agreed that *CrLFY2* promoter analysis and/or in situ hybridization, as well as controls for the RNAi analysis, are needed. *eLife* recommends a \"reject\" decision if it is likely that additional experiments will take more than 2 months. We therefore collectively agreed that rejection was the correct decision -- however, the reviewers were all enthusiastic about the work and would strongly support re-submission to *eLife* if the requested experiments were included.

Reviewer \#1:

This manuscript is the first to examine gene function using reverse genetics in a stably transformed fern, which is very exciting. The authors focus on *LEAFY*, which has been well characterized in moss and Arabidopsis. While it was previously known that the two Ceratopteris *LEAFY* genes are expressed in gametophytes and sporophytes, this study examines more detailed expression patterns and addresses their functions in both Ceratopteris generations by RNAi. The topic is very interesting and important in understanding fern development and plant evolution in general.

Comments/questions relating to the gene expression studies:

1\) Please describe the *LFY* promoter more; e.g., does it include all sequences upstream of the a) transcript initiation site b) the translation start site c) second exon that would include the first intron? This may be in the details of the supplementary figures (I couldn\'t tell), but I think it\'s important to include such details in the text.

2\) Any reason why *LFY2* promoter-GUS expression wasn\'t included? The conclusion that two *LFY* homologs in Ceratopteris function together to control of apical cell identity would be better supported if the expression patterns of *CrLFY2* were examined using the same strategy (GUS reporter).

3\) I assume that a T~1~ sporophyte is the product a self of a gametophyte that came from the spores of a transformed sporophyte that was selected then regenerated from bombarded callus. Is this correct?

My comments/questions relating to the RNAi lines:

1\) What does phenotypic screening in the line \"phenotypic screening identified 10 lines with similar developmental defects that were associated with reduced *CrLFY* expression\" mean? My concern here is that the phenotypes described may be caused by the callus derived shoot regeneration process, which typically happens during callus regeneration in many different plant species. The authors need to carefully characterize the phenotypes of multiple individual transgenic plants together with their segregated siblings that do not contain the RNAi construct. I would also suggest performing vigorous genetic analyses to clearly define and confirm the phenotypes from multiple independent transgenic lines (i.e., backcrossing to or by wild type and examining whether the phenotype is tightly correlated to the repression of *LFY* genes in the F2 population). Wouldn\'t selection for drug resistance be useful here?

2\) If some of the lines never develop gametophytes with gametangia, how were T~2~ or T~3~ lines generated?

My comments regarding the Discussion:

Much of this study is based on a single fern (Ceratopteris) and on one gene (*LFY*). For this reason, I regard the discussion of the evolutionary trajectory of *LFY* to be very speculative. The last sentence \"if a pathway for regulating stem cell activity was co-opted from the gametophyte into the sporophyte, it was the *LFY* pathway\" should be changed to.. if a pathway for regulating stem cell activity was co-opted from the gametophyte into the sporophyte, the pathway involving *LFY* is more likely than the *KNOX* pathway.\" There could be other pathways as well.

Because the Discussion focuses on evolution, it is important that this study include at least some supporting data from at least one other fern.

Reviewer \#2:

Comparative analyses between bryophytes and angiosperms have been provided the information how gene function evolved to facilitate developmental innovations during land plant evolution as the authors pointed out. Ferns are one of missing link though it takes very important position during land plant evolution. Ceratopteris has been recognized as a model fern because of the early life cycle. The establishment of transformation technique in Ceratopteris became a breakthrough in this field (Muthukumar et al., 2013, Plant Physiol.; Plackett et al., 2014; Bui et al., 2015, BMC Res. Notes). *LFY* is one of well-studied genes among land plant lineages (e.g. Maizel et al., 2005; Sayou et al., 2014). Functional analysis of fern Ceratopteris *LFY* genes should be interesting topic for many readers.

The authors carefully examined the expression level of two Ceratopteris *LFY* genes, *CrLFY1* and *2*, spatial expression analysis of *CrLFY1* using promoter analysis, and suppression analysis of *CrLFY1* and *CrLFY2* activity by RNAi. This paper will be one of model case of EvoDevo study using the fern Ceratopteris. The quality of analyses and figures is excellent, however two questions remain.

1\) Why the authors did not provide the expression data by *CrLFY2* promoter analysis nor in situ hybridization data of *CrLFY2*.

The authors indicated that *CrLFY1* and *CrLFY2* were differentially expressed during the Ceratopteris life cycle (subsection "*CrLFY1* and *CrLFY2* transcripts accumulate differentially during the Ceratopteris lifecycle") and *CrLFY1* and *CrLFY2* act partially redundantly to maintain indeterminacy of the shoot apex in Ceratopteris (subsection "*CrLFY1* regulates activity of the sporophyte shoot apex"). Also they discussed that the duplicate *CrLFY* genes therefore act at least partially redundantly during shoot development in Ceratopteris (Discussion, first paragraph). It would be very helpful to understand the difference and redundancy in the function of *CrLFY1* and *2*, if they have the spatial expression data of *CrLFY2*.

The authors described that no GUS activity was detected in unfertilized archegonia of *CrLFY1~pro~::GUS* gametophytes (subsection "Spatial expression patterns of *CrLFY1* are consistent with a retained ancestral role to facilitate cell divisions during embryogenesis"). In the case, the expression of *CrLFY2* should to be important to function in the gametophytes. The spatial expression patterns of *CrLFY2* would provide important information for the hypothesis. Since the authors succeeded both transformation and in situ hybridization in Ceratopteris, it seems technically possible to provide these data.

2\) The authors provided that RNAi suppression analysis of *CrLFY1* and *CrLFY2* by using 4 different constructs and used wild type strain as control. The strain introduced with the vector is better to use as control. Transformation trials from three constructs produced a few transformants and the phenotype from same construct is different. The authors explained the difference of phenotype was because of the expression level of *CrLFY1* or *CrLFY2*, though also should consider the effect of transformation procedure or transformation with the vector per se.

Reviewer \#3:

This manuscript analyses the role of the *LEAFY* transcription factor in the fern Ceratopteris. The major finding is that *LEAFY* is expressed and essential for apical cell division both in the gametophyte and the sporophyte. *LEAFY* is a transcription factor playing a major role during flower development in angiosperms. It is present in most charophytes algae and all land plants. Its role has only been analyzed genetically in the moss *Physcomitrella patens* where it controls cell division in the sporophyte. In angiosperms, there is a growing body of evidence that *LEAFY* plays a role in meristem development (not necessarily flower meristem) as illustrated in various species such as rice, cucumber or pea. The evolutionary scenario describing how *LEAFY* could have been co-opted from a role in sporophyte cell division to flower development has remained very uncertain because of the lack of genetics in plant groups such as ferns and gymnosperms. In species belonging to these groups, one had to rely on expression patterns and inference on the function but there was, until now, no genetic evidence.

The work presented here represents a great leap forward by partially filling the gap between mosses and angiosperms. It analyses the expression and function of the *LEAFY* genes in Ceratopteris and concludes that *LEAFY* plays a role in apical growth in the sporophyte and gametophyte. To my opinion, these conclusions are well supported. Generating and analysing fern transgenics is a challenging but extremely useful task to learn about plant evolution in the major plant families. Even if the work is based mostly on expression pattern and mutant description (and it might look a bit old-fashioned at first glance for the lack of attempt to identify regulated genes), I am convinced that the results presented here are of great significance not only for the *LEAFY* research field but as an example of how a transcription factor can be co-opted along plant evolution to acquire a key role in angiosperms. Such a trajectory could not have been guessed without this type of seminal work in more basal plants.

My only concern is that this work is not so easy to follow for those who are not familiar with fern development. I suggest adding a scheme describing Ceraptopteris life cycle (and naming relevant organs and tissues) that can referred to as a guide for each figure showing expression patterns (GUS or mRNA) or phenotypes.

10.7554/eLife.39625.038

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

Many thanks for the well-considered handling of our manuscript. The reviews and decision are perfectly understandable based on the contents of the submitted manuscript and I am grateful to the reviewers for their enthusiasm and informed critique. I am especially grateful for the acceptance that any further experiments would be impossible in two months. However, I attach a document that provides some extra information relating to the two main issues -- *CrLFY2* promoter analysis and RNAi controls. I have highlighted the main points where we can add information to clarify/justify our approach. I do believe that the conclusions we have made are robust and justifiable but accept that we could be more circumspect in the discussion.

In brief:

1\) The *CrLFY2* analysis is impossible until a genome sequence is available.

2\) We chose wild-type as the standard control for RNAi lines because null segregants are rarely that after bombardment in Ceratopteris -- each is likely to contain a fragment of the construct even if the hairpin is absent.

> Reviewer \#1:
>
> \[...\] Comments/questions relating to the gene expression studies:
>
> 1\) Please describe the LFY promoter more; e.g., does it include all sequences upstream of the a) transcript initiation site b) the translation start site c) second exon that would include the first intron? This may be in the details of the supplementary figures (I couldn\'t tell), but I think it\'s important to include such details in the text.

A diagrammatic representation of the promoter and 5'UTR structure was included as part of Figure 1---figure supplement 2 and referred to in the Materials and methods. Details are now also in the

text of the Results.

> 2\) Any reason why LFY2 promoter-GUS expression wasn\'t included? The conclusion that two LFY homologs in Ceratopteris function together to control of apical cell identity would be better supported if the expression patterns of CrLFY2 were examined using the same strategy (GUS reporter).

It would have been ideal to include expression data for both genes and numerous attempts were made to obtain a *CrLFY2* promoter fragment for use in GUS expression studies alongside *CrLFY1*, but this proved impossible in the absence of a reference genome. Details of what we attempted to do are now in the Materials and methods, and reference to the fact that we were unable to amplify a *CrLFY2* promoter for use in GUS assays is now in the results text. We also refer to the fact that expression could not be determined in situ as we were unable to identify a fragment that clearly distinguished *CrLFY1* and *CrLFY2* in hybridizations (in main text and Materials and methods).

> 3\) I assume that a T~1~ sporophyte is the product a self of a gametophyte that came from the spores of a transformed sporophyte that was selected then regenerated from bombarded callus. Is this correct?

This is now clearly articulated in the Materials and methods.

> My comments/questions relating to the RNAi lines:
>
> 1\) What does phenotypic screening in the line \"phenotypic screening identified 10 lines with similar developmental defects that were associated with reduced CrLFY expression\" mean? My concern here is that the phenotypes described may be caused by the callus derived shoot regeneration process, which typically happens during callus regeneration in many different plant species. The authors need to carefully characterize the phenotypes of multiple individual transgenic plants together with their segregated siblings that do not contain the RNAi construct.

We compared the phenotype of transgenic lines containing the full transgene with that of wild-type and of transgenic controls that lacked the RNAi hairpin (no hairpin controls -- NHC). Wild type and NHC lines were phenotypically indistinguishable and NHC lines did not show suppression of endogenous *LFY* expression (see new Figure 6, Supplementary file 6, Table 1). Because DNA fragmentation after bombardment is common, these lines still contain part of the transgene cassette. Importantly, the new controls do not change the interpretation of any of the RNAi data.

> I would also suggest performing vigorous genetic analyses to clearly define and confirm the phenotypes from multiple independent transgenic lines (i.e., backcrossing to or by wild type and examining whether the phenotype is tightly correlated to the repression of LFY genes in the F2 population). Wouldn\'t selection for drug resistance be useful here?

We did not do this routinely but because the selection antibiotic prevented fertilization of gametophytes, we did in some cases grow T~1~ gametophyte populations on non-selective medium and allow unrestricted mating to occur within lines which were determined to be a mixed population of transgenic and non-transgenic individuals (based on relative survival on and off antibiotic selection). Transgenic individuals were then identified post-fertilization by screening directly for antibiotic resistance. In these cases, T~1~ sporophytes would represent either hemizygous or homozygous individuals, some of the hemizygous being effectively backcrossed to wild-type. Gel-blot analysis found that sibling sporophytes generated within a line in this manner had a similar pattern of T-DNA insertions, implying very little genetic variation within each T~1~ population. There was also very little phenotypic variation between individuals.

> 2\) If some of the lines never develop gametophytes with gametangia, how were T~2~ or T~3~ lines generated?

There were only two lines in which 100% of the gametophytes arrested (F14 and E8). It was thus possible to look at sporophyte development in the remaining 8 (7 of which are shown in new Figure 6).

> My comments regarding the Discussion:
>
> Much of this study is based on a single fern (Ceratopteris) and on one gene (LFY). For this reason, I regard the discussion of the evolutionary trajectory of LFY to be very speculative. The last sentence \"if a pathway for regulating stem cell activity was co-opted from the gametophyte into the sporophyte, it was the LFY pathway\" should be changed to.. if a pathway for regulating stem cell activity was co-opted from the gametophyte into the sporophyte, the pathway involving LFY is more likely than the KNOX pathway.\" There could be other pathways as well.

This sentence has been changed.

> Because the Discussion focuses on evolution, it is important that this study include at least some supporting data from at least one other fern.

This is not feasible at this stage because of the paucity of other model fern systems, neither has it been a requirement in other evo-devo studies e.g., with mosses (focused on *Physcomitrella patens*) or liverworts (*Marchantia polymorpha*). The point of the Discussion is to set up a hypothesis that can be further validated in future studies.

> Reviewer \#2:
>
> \[...\] The authors carefully examined the expression level of two Ceratopteris LFY genes, CrLFY1 and 2, spatial expression analysis of CrLFY1 using promoter analysis, and suppression analysis of CrLFY1 and CrLFY2 activity by RNAi. This paper will be one of model case of EvoDevo study using the fern Ceratopteris. The quality of analyses and figures is excellent, however two questions remain.
>
> 1\) Why the authors did not provide the expression data by CrLFY2 promoter analysis nor in situ hybridization data of CrLFY2.
>
> The authors indicated that CrLFY1 and CrLFY2 were differentially expressed during the Ceratopteris life cycle (subsection "CrLFY1 and CrLFY2 transcripts accumulate differentially during the Ceratopteris lifecycle") and CrLFY1 and CrLFY2 act partially redundantly to maintain indeterminacy of the shoot apex in Ceratopteris (subsection "CrLFY1 regulates activity of the sporophyte shoot apex"). Also they discussed that the duplicate CrLFY genes therefore act at least partially redundantly during shoot development in Ceratopteris (Discussion, first paragraph). It would be very helpful to understand the difference and redundancy in the function of CrLFY1 and 2, if they have the spatial expression data of CrLFY2.
>
> The authors described that no GUS activity was detected in unfertilized archegonia of CrLFY1~pro~::GUS gametophytes (subsection "Spatial expression patterns of CrLFY1 are consistent with a retained ancestral role to facilitate cell divisions during embryogenesis"). In the case, the expression of CrLFY2 should to be important to function in the gametophytes. The spatial expression patterns of CrLFY2 would provide important information for the hypothesis. Since the authors succeeded both transformation and in situ hybridization in Ceratopteris, it seems technically possible to provide these data.

See response 2 to reviewer 1.

> 2\) The authors provided that RNAi suppression analysis of CrLFY1 and CrLFY2 by using 4 different constructs and used wild type strain as control. The strain introduced with the vector is better to use as control. Transformation trials from three constructs produced a few transformants and the phenotype from same construct is different. The authors explained the difference of phenotype was because of the expression level of CrLFY1 or CrLFY2, though also should consider the effect of transformation procedure or transformation with the vector per se.

See response 4 to reviewer 1.

> Reviewer \#3:
>
> \[...\] My only concern is that this work is not so easy to follow for those who are not familiar with fern development. I suggest adding a scheme describing Ceraptopteris life cycle (and naming relevant organs and tissues) that can referred to as a guide for each figure showing expression patterns (GUS or mRNA) or phenotypes.

We have inserted a schematic of the lifecycle showing morphology at different stages as new Figure 2. Citations of studies describing details of Ceratopteris development and morphology have now also been included in the text where appropriate.
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